WO2013066742A1 - Antiseptic cap equipped syringe - Google Patents
Antiseptic cap equipped syringe Download PDFInfo
- Publication number
- WO2013066742A1 WO2013066742A1 PCT/US2012/062078 US2012062078W WO2013066742A1 WO 2013066742 A1 WO2013066742 A1 WO 2013066742A1 US 2012062078 W US2012062078 W US 2012062078W WO 2013066742 A1 WO2013066742 A1 WO 2013066742A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cap
- antiseptic
- syringe
- chamber
- antiseptic cap
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M39/16—Tube connectors; Tube couplings having provision for disinfection or sterilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M39/16—Tube connectors; Tube couplings having provision for disinfection or sterilisation
- A61M39/162—Tube connectors; Tube couplings having provision for disinfection or sterilisation with antiseptic agent incorporated within the connector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/20—Closure caps or plugs for connectors or open ends of tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
- A61M2005/31506—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit formed as a single piece, e.g. moulded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0019—Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1033—Swivel nut connectors, e.g. threaded connectors, bayonet-connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/001—Apparatus specially adapted for cleaning or sterilising syringes or needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3135—Syringe barrels characterised by constructional features of the proximal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31513—Piston constructions to improve sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
- A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw
Definitions
- the present invention relates to an antiseptic cap equipped syringe, and more specifically to antiseptic caps disposed on syringes.
- Catheters are widely used to treat patients requiring a variety of medical procedures. Catheters can either be acute, or temporary, for short-term use or chronic for long-term treatment. Catheters are commonly inserted into central veins (such as the vena cava) from peripheral vein sites to provide access to a patient's vascular system. Catheters offer many advantages for patients; for example, chronic catheters provide ready access without repeated punctures or repeated vessel cannulation for administration of large volumes of fluids, nutrients and medications and for withdrawal of blood on an intermittent basis. With respect to the use of catheters for infusion of fluids, examples include the infusion of drugs, electrolytes or fluids used in chemotherapy. In chemotherapy, catheters are used for infusion of drugs on an intermittent basis, ranging from daily to weekly.
- catheters in hyperalimentation treatment, wherein the catheters are usually used for infusion of large volumes of fluids.
- catheters are commonly used—usually three times per week—for aspiration of blood for dialysis treatment and rapid return of the blood to circulation after treatment.
- AV arteriovenous
- bridge arteriovenous graft
- a large bore venous line catheter is typically required for hemodialysis.
- Catheters used for hemodialysis usually include two relatively large diameter lumens (usually molded as one catheter) for aspiration and rapid return of blood required during the hemodialysis procedure.
- One lumen of such a catheter is used for aspiration, or removal, of blood, while the other lumen is used for returning the blood to the patient's bloodstream.
- Catheter connections such as, for example, connections of catheters to dialysis machine tubing, to IV line tubing, to infusion ports and to catheter caps, which are used to seal the end of a catheter to protect the sterility of the catheter and prevent fluid loss and/or particle contamination, are most often made utilizing the medical industry's standardized Luer taper fittings.
- These fittings which may either be male couplings or female couplings, include a tapered end of standardized dimensions. Coupling is made by the press-fit of mating parts. A threaded lock-fit or other type of securing mechanism is commonly utilized to ensure the integrity of the pressure fit of the Luer fittings.
- Catheters especially chronic venous catheters, provide challenges in their use.
- One such challenge is that such catheters can become occluded by a thrombus.
- the lumens of the catheter are often filled with a lock solution of a concentrated solution of the commonly used anticoagulant, heparin (up to 10,000 units of heparin per catheter lumen).
- lock solution refers to a solution that is injected or otherwise infused into a lumen of a catheter with the intention of allowing a substantial portion of the lock solution to remain in the lumen and not in the systemic blood circulation until it is desired or required to access that particular lumen again, typically for additional treatment, i.e., infusion or withdrawal of fluid.
- alternative lock solutions with the goal of improving the patency rates of vascular catheters.
- lower-alcohol containing locking solutions are under development wherein the lower alcohols include ethanol, propanol and butanol.
- Anti-microbial and or anticoagulant additives can optionally be added to the lower-alcohol containing locking solution.
- the lock solution can remain in the lumen for a desired amount of time lasting from about 1 hour to 3 or 4 days or longer.
- flush procedures suggest two techniques: 1) at the end of the flush solution delivery, the user maintains pressure on the syringe plunger while clamping the I.V. line; or 2) while delivering the last 0.5 ml of flush solution disconnect the syringe from the I.V. port or clamp the IV. line. Either technique maintains positive pressure on the fluid in the catheter to prevent reflux of fluid and blood.
- the present invention relates to an antiseptic cap and syringe combination.
- the combination includes a syringe barrel having an access point connection, and a tip cap having a proximal chamber and a distal chamber.
- the proximal chamber releasably receives and engages the access point connection of the syringe.
- the distal chamber removably receives and engages an antiseptic cap.
- the distal chamber has a plurality of ribs for coacting with a plurality of ribs on the antiseptic cap to prevent relative rotational movement between the distal chamber and the antiseptic cap.
- a combination syringe tip cap and antiseptic cap includes a first chamber having means for releasably engaging an access point connection on a syringe.
- a second chamber is formed integrally with the first chamber.
- An antiseptic cap is positioned within the second chamber, and means for releasably engaging the antiseptic cap is provided in the second chamber.
- a method of storing an antiseptic cap of a syringe includes the steps of providing a syringe having a barrel, a plunger, an access point connection and a tip cap, providing a chamber on the syringe, and releasably engaging an antiseptic cap within the chamber.
- a method of using an antiseptic cap disposed on a tip cap of a syringe having a barrel, a plunger, an access point connection and a tip cap is also provided.
- the method includes the steps of removing the tip cap from the syringe, and using the syringe.
- the method further includes the step of removing a cover over the antiseptic cap. Steps of using a tip cap to position the antiseptic cap on an access point, and removing the tip cap from engagement with the antiseptic cap, leaving the antiseptic cap on the access point are included.
- a combination syringe tip cap and antiseptic cap includes a first chamber having means for releasably engaging an access point connection on a syringe, and a second chamber formed integrally with the first chamber.
- An antiseptic cap assembly has an antiseptic cap, and the antiseptic cap assembly is removably positioned within the second chamber.
- an antiseptic cap and syringe combination in another embodiment, includes a syringe barrel having an access point connection, and a plunger received at one end by the barrel.
- the plunger has a chamber removeably receiving an antiseptic cap assembly at a second end.
- a tip cap has a proximal chamber for releasably receiving the access point connection of the syringe, and a distal chamber for removeably receiving a second antiseptic cap assembly.
- an antiseptic cap and syringe combination in another embodiment, includes a syringe barrel having an access point connection, and a plunger received at one end by the barrel.
- a chamber is interconnected with the syringe barrel for removeably receiving an antiseptic cap assembly.
- an antiseptic cap and syringe combination in another embodiment, includes a syringe barrel having an access point connection and an antiseptic cap.
- a flexible ring for engaging the access point, and a chamber interconnected with the syringe barrel for removeably receiving an antiseptic cap are provided.
- an antiseptic cap and syringe combination in another embodiment, includes a syringe barrel having an access point connection and a tip cap including a proximal chamber releasably receiving and engaging the access point connection of the syringe.
- a distal projection extends from the tip cap, and an antiseptic cap assembly has a chamber for receiving the distal projection of the tip cap at one end and an antiseptic cap at the other end.
- an antiseptic cap and syringe combination in another embodiment, includes a syringe barrel having an access point connection, a tip cap including a proximal chamber for engaging the access point connection and a distal attachment chamber, and a cap assembly.
- the cap assembly includes an engagement protrusion for removeably engaging the tip cap.
- FIG. 1 is a perspective view of an antiseptic cap equipped plunger and syringe barrel assembly prior to connection of a syringe tip to an access point to a central venous catheter;
- FIG. 2 is a perspective view of an antiseptic cap equipped plunger and syringe barrel assembly with the syringe tip connected to an access point to a central venous catheter;
- FIG. 3 is a perspective view of an antiseptic cap equipped plunger and syringe barrel assembly prior to connection of the antiseptic cap to an access point to a central venous catheter;
- FIG. 4 is a perspective view of an antiseptic cap equipped plunger and syringe barrel assembly after connection of the antiseptic cap to an access point to a central venous catheter;
- FIG. 5 is a perspective view assembly drawing of an antiseptic cap equipped plunger
- FIG. 6 is a perspective view of an antiseptic cap equipped plunger in a partially assembled state
- FIG. 7 is a perspective view of the antiseptic cap equipped plunger of FIG. 6 with a top seal
- FIG. 8 is a perspective view of an antiseptic cap equipped plunger of FIG. 7 mounted in a lumen of a syringe barrel;
- FIG. 9 is a side view in cutaway of an antiseptic cap equipped plunger and syringe barrel assembly
- FIG. 10 shows an exploded view of a detail of FIG. 9 of one embodiment of the antiseptic cap equipped plunger and syringe barrel assembly
- FIG. 11 shows an exploded view of a detail of FIG. 9 of another embodiment of the antiseptic cap equipped plunger and syringe barrel assembly
- FIGS. 12-14 show various embodiments of grips of the antiseptic cap equipped plunger assembly
- FIGS. 15-17 show various views of one embodiment antiseptic cap equipped plunger and syringe barrel assembly with a barrel lock to resist rotation of the plunger assembly with respect to the syringe barrel;
- FIG. 18 shows another embodiment of a barrel lock to resist rotation of the plunger assembly with respect to the syringe barrel;
- FIGS. 19-20 show various views of another embodiment antiseptic cap equipped plunger and anti-reflux syringe barrel assembly with a barrel lock to resist rotation of the plunger assembly with respect to the syringe barrel;
- FIG. 21 shows a perspective view of another embodiment antiseptic cap equipped plunger and syringe barrel assembly with a barrel lock to resist rotation of the plunger assembly with respect to the syringe barrel;
- FIGS. 22a,b are respectively a perspective view of an antiseptic cap without a sponge and with a sponge;
- FIGS. 23 and 24 are different embodiments of the antiseptic cap with varying gripping features
- FIG. 25 is a perspective view of the antiseptic cap of FIG. 22b prior to docking with a valve
- FIG. 26 is a perspective view of the antiseptic cap of FIG. 22b docked with a valve
- FIG. 27 is a side view in cutaway of the antiseptic cap and valve assembly shown in FIG. 26;
- FIGS. 28-30 are side views in cutaway of two different embodiments of the antiseptic cap
- FIGS. 31 a,b are, respectively, side views in cutaway showing an antiseptic cap with a centrally disposed actuation post mounted on a valve with the valve in the unactivated and activated positions;
- FIGS. 32 and 33 are side views in cutaway showing two different embodiments of an antiseptic cap having a molded sponge
- FIG. 34 is a side view in cutaway showing another embodiment of an antiseptic cap having a molded sponge docked to a valve;
- FIG. 35 is a side view in cutaway showing a step of attaching a molded sponge to an antiseptic cap
- FIG. 36 is a side view in cutaway showing a step of delivering an antiseptic compound to a molded sponge positioned within a cap;
- FIG. 37 shows a side view in cutaway of an antiseptic cap docking to a valve with the antiseptic cap having an antiseptic coating;
- FIG. 38 shows a perspective view of an antiseptic cap in a blister package
- FIG. 39 is a side cross-sectional view of an antiseptic cap with a thread cover
- FIG. 40 is a side cross-sectional view of an antiseptic cap with a thread cover
- FIG. 41 is a side cross-sectional view of an antiseptic cap with a thread cover
- FIGS. 42a,b are perspective front and back views of an antiseptic cap with a thread cover connected to a Cardinal SMART SITE access site;
- FIGS. 43 a,b are perspective front and back views of an antiseptic cap without a thread cover connected to a Cardinal SMART SITE access site;
- FIGS. 44 a,b are perspective front and back views of an antiseptic cap with a thread cover connected to a Hospira (ICU) CI 000 Clave access device;
- FIGS. 45 a,b are perspective front and back views of an antiseptic cap without a thread cover connected to a Hospira (ICU) CIOOO Clave access device;
- FIGS. 46 a,b are perspective front and back views of an antiseptic cap with a thread cover connected to a B. Braun ULTRASITE access device;
- FIGS. 47 a,b are perspective front and back views of an antiseptic cap without a thread cover connected to a B. Braun ULTRASITE access device;
- FIGS. 48 a,b are perspective front and back views of an antiseptic cap with a thread cover connected to a Rymed INVISION PLUS access device;
- FIGS. 49 a,b are perspective front and back views of an antiseptic cap without a thread cover connected to a Rymed INVISION PLUS access device;
- FIG. 50 is a side cross-sectional view of an antiseptic cap with a thread cover connected to a Cardinal SMARTSITE PLUS access device;
- FIG. 51 is a side cross-sectional view of an antiseptic cap with a thread cover connected to a Cardinal SMARTSITE PLUS access device and the thread cover having a reduced diameter when compared to the thread cover shown in FIG. 50;
- FIG. 52 is a side cross-sectional view of an antiseptic cap with a thread cover connected to a Hospira (ICU) CIOOO Clave access device having a thread cover with an alternative profile;
- ICU Hospira
- FIG. 53 is an assembly view of an antiseptic cap and cup holder equipped plunger and syringe barrel system
- FIG. 54 is an assembly view of a cup-holder-antiseptic cap assembly adjacent a plunger and syringe barrel system
- FIG. 55 is a side view in cross-section of an antiseptic cap and cup holder equipped plunger and syringe barrel assembly
- FIG. 56a is a perspective view of a medical access device adjacent an antiseptic cap equipped plunger and syringe barrel assembly with a lid stock peeled back in preparation for docking;
- FIG. 56b is a perspective view of a medical access device docked to an antiseptic cap equipped plunger and syringe barrel assembly;
- FIG. 56c is a perspective view of a medical access device docked to an antiseptic cap adjacent a plunger and syringe barrel assembly;
- FIG. 57 is an enlarged view of a cup holder and antiseptic cap assembly adjacent an open and empty chamber of a syringe plunger;
- FIG. 58 is an enlarged view of a cup holder and antiseptic cap assembly positioned within a chamber of a syringe plunger;
- FIG. 59 is a perspective view of an alternative embodiment of an antiseptic cap assembly adjacent a syringe plunger and barrel assembly;
- FIG. 60 is a perspective view of an alternative embodiment of an antiseptic cap assembly docked to a syringe plunger and barrel assembly;
- FIG. 61 is a perspective view of an alternative embodiment of an antiseptic cap assembly docked to a syringe plunger and barrel assembly with an outer wall being transparent to reveal interior portions of the assembly;
- FIG. 62 is a perspective view of a tip cap assembly having an antiseptic cap attached to a syringe
- FIG. 63 is a cross-sectional view of a tip cap having an antiseptic cap attached to a syringe
- FIG. 64 is an exploded, perspective view showing an antiseptic cap and a tip cap
- FIG. 65 is an exploded, perspective view showing an antiseptic cap holder assembly, a tip cap, and a syringe;
- FIG. 66 is an exploded, perspective view showing an antiseptic cap holder assembly, a tip cap, and a syringe;
- FIG. 67A is a cross-sectional view of an antiseptic cap assembly attached to a syringe
- FIG. 67B is a cross-sectional view of an antiseptic cap assembly and a flexible cap
- FIG. 68 is a side view of an antiseptic cap holder assembly attached to a tip cap attached to a syringe
- FIG. 69 is a perspective view of an antiseptic cap holder assembly
- FIG. 70 is a perspective view of a tip cap
- FIG. 71 is a cross-sectional view of the antiseptic cap holder assembly of FIG. 69 and the tip cap of FIG. 70 disengaged and unlocked;
- FIG. 72 is a cross-sectional view of the antiseptic cap holder assembly of FIG. 69 and the tip cap of FIG. 70 engaged and locked;
- FIG. 73 is a perspective view of a syringe having a plunger with a cap holder assembly that is manually removable from the plunger;
- FIG. 74 is a cross-sectional view of the syringe, plunger, and cap holder assembly of FIG. 73;
- FIGS. 75 and 76 are sequential views, showing the process of manually removing the cap holder assembly from a chamber of the plunger;
- FIG. 77 is a perspective view of another embodiment of a chamber of a plunger with ribs having grooves;
- FIG. 78 is a cross-sectional view of the chamber of FIG. 77;
- FIG. 79 is a cross-sectional view of a cap holder assembly positioned within the chamber shown in FIG. 78;
- FIG. 80 is a cross-sectional view of a cap holder assembly partially removed from the chamber shown in FIG. 78;
- FIG. 81 is a cross-sectional view of another embodiment of a chamber of a plunger with ribs having two sets of grooves;
- FIG. 82 is a cross-sectional view of a cap holder assembly positioned within the chamber shown in FIG. 81;
- FIG. 83 is a cross-sectional view of a cap holder assembly partially removed from the chamber shown in FIG. 81;
- FIG. 84 is a perspective view of another embodiment of a plunger having sidewalls with recessed areas
- FIG. 85 is a perspective view of another embodiment of a plunger having two or more sidewalls positioned at angles of greater than ninety degrees from each other to provide access to the chamber;
- FIG. 86 is a perspective view of another embodiment of a syringe having a flange with receptacles for receiving a cap holder assembly;
- FIG. 87 is a perspective view of the syringe shown in FIG. 86 with a cap holder assembly positioned in a receptacle;
- FIG. 88 is a perspective view of a flange connector panel having a cap holder assembly receptacle and a flange slot in a sidewall;
- FIG. 89 is a top view of the flange connector panel of FIG. 88 connected to a gripping flange of a syringe;
- FIG. 90 is a perspective view of another embodiment of a flange connector panel having a flange slot in another sidewall;
- FIG. 91 is a top view of the flange connector panel of FIG. 90 connected to a gripping flange of a syringe;
- FIG. 92 is a perspective view of another embodiment of a syringe with a gripping flange having engagement teeth
- FIG. 93 is a perspective view of a flange connector panel that engages with the gripping flange of FIG. 92;
- FIG. 94 is a perspective view of another embodiment of a flange connector panel for connection with a gripping flange having a lip;
- FIG. 95 is a perspective view of a flange connector panel that attaches to the gripping flange of FIG. 94;
- FIG. 96 is a perspective view of a plunger and cap holder assembly connected by a frangible attachment
- FIG. 97 is a cross-sectional view of the plunger and cap holder assembly of FIG.
- FIG. 98 is an exploded view of a plunger having a transverse opening to receive a cap holder assembly
- FIG. 99 is an exploded view of another embodiment of a plunger having a transverse opening for receiving a cap holder assembly
- FIG. 100 is a front view of the plunger of FIG. 99;
- FIG. 101 is a side view of the plunger of FIG. 99;
- FIG. 102 is a perspective view of another embodiment of a cap holder assembly having a locking flange
- FIG. 103 is a partial perspective view of a plunger having a locking chamber
- FIG. 104 is a partial cross-sectional view of the cap holder assembly of FIG. 102 and the plunger of FIG. 103 disengaged and unlocked;
- FIG. 105 is a cross-sectional view of the cap holder of the cap holder assembly of FIG. 102 and the plunger of FIG. 103 engaged and locked;
- FIG. 106 is a perspective view of another embodiment of a plunger having a locking lever and a cap holder assembly disposed therein;
- FIG. 107 is a cross-sectional view of the plunger and cap holder assembly of FIG.
- FIG. 108 is a side view of the locking lever of FIGS. 106 and 107;
- FIG. 109 is a cross-sectional view of another embodiment of the plunger and cap holder assembly that includes a locking lever with a toe;
- FIG. 110 is a side view of the locking lever of FIG. 109;
- FIG. Ill is a side view of a cap holder assembly and a plunger each having an adhesive material thereon;
- FIG. 112 is a side view of a cap holder assembly and a plunger with compressible material in an uncompressed state
- FIG. 113 is a side view of a cap holder assembly and plunger with the
- FIG. 114 is a cross-sectional view of a plunger and a cap holder assembly, wherein the cap holder assembly flange is positioned a distance away from the plunger flange;
- FIG. 115 is an exploded view of a plunger having a locking flange attached thereto and a cap holder assembly
- FIG. 116 is a perspective view of the plunger and the cap holder assembly of FIG. 115 disposed in the plunger;
- FIG. 117 is a top view of the locking flange of FIGS. 115 and 116.
- FIG. 118 is a top view of another embodiment of the locking flange of FIGS. 115 and 116. DETAILED DESCRIPTION OF THE INVENTION
- FIGS. 1 and 2 show an antiseptic cap equipped plunger and syringe barrel assembly 10 having an antiseptic cap equipped plunger (or piston) assembly 12 and a syringe barrel 14.
- the barrel 14 has a side wall 16 defining a chamber 18 and the barrel has a proximal end 20 and a distal end 22.
- the proximal end 20 has an opening 23 to the chamber 18 and a flange 24 extending radially outwardly from the wall 16.
- the flange 24 has upper and lower surfaces 26, 28 and provides gripping surfaces for a user of the assembly 10.
- the distal end 22 of the barrel 14 has an end wall 30 and an elongate tip 32 extending distally therefrom and having a passageway 34 therethrough and in fluid communication with the chamber 18.
- the distal end wall 30, in one preferred form of the invention, is generally conically shaped and, as is well known in the art, can have a locking luer collar 35 concentrically surrounding the tip 32 and having a set of threads 37 on an inside surface thereof.
- the luer collar 35 allows for attaching a needle or a cannula to the syringe assembly and for docking the assembly to mating threads located on other devices such as valves and injection sites.
- FIG. 1 shows the syringe assembly proximate an access site 38 having a valve 39 controlling access to a lumen of a tubing 41.
- the chamber 18 of the syringe assembly 10 will be filled with a locking solution or a flush solution for use with an indwelling, central venous catheter.
- a locking or flush solution for use with an indwelling, central venous catheter.
- Suitable locking or flushing solutions will be set forth below.
- the flush or locking solution is injected into a fluid access site of the catheter to clean and disinfect the catheter and can be withdrawn from the catheter or allowed to remain in an end portion of the catheter to serve as a barrier to the ingress of pathogens and contaminants.
- the antiseptic cap plunger assembly 12 has an elongate shaft 40, a proximal end 42 and a distal end 44.
- the elongate shaft 40 in one preferred form of the invention, is generally cruciform in cross-sectional shape.
- a stopper or piston 50 is connected to the distal end 44 of the plunger 12.
- the piston 50 is dimensioned such that when inserted into the syringe barrel chamber 18 an outer circumferential surface of the piston is in fluid-tight engagement with an inner surface 54 of the syringe barrel.
- the piston assembly 12 when moved proximally (or when being withdrawn) can draw fluid into the chamber and when moved distally (or when inserted into the syringe chamber) can drive fluid out of the chamber.
- FIG. 1 shows the piston assembly 12 partially inserted into the syringe chamber and
- FIG. 2 shows the piston assembly fully inserted into the syringe chamber to deliver fluid to the tubing 41.
- a housing 60 is located at the proximal end of the plunger assembly 12 and has a wall 62 defining a chamber 64 having an open end 66 which can be sealed by any suitable structure or material such as a cap or by a foil material 68.
- An optional annular flange 70 extends radially outwardly from the wall 62 and provides a surface upon which the sealing structure can be attached.
- FIG. 5 shows a cap assembly 80 proximate the chamber 64 of the housing 60 and FIG. 6 shows the cap assembly 80 positioned within the chamber 64.
- the cap assembly 80 has a cap 82 having a wall 83 defining a chamber 84 containing an absorbent material 86 such as a sponge.
- the sponge 86 in a preferred form of the invention, is wetted or soaked with an agent such as an antiseptic, anticoagulant or antimicrobial ("antiseptic solution”) and can be selected from the locking and flushing solutions set forth below or the antiseptic solutions set forth below.
- the cap 82 has an interior surface 87 with a set of threads 88 for mating with a set of threads on the access site 38.
- FIGS. 7 and 8 show the cap assembly 80 sealed with a foil material or lid stock material 68 which can be attached to the flange 70 by any suitable method such as by adhesives or by conductive or inductive heat sealing techniques.
- FIG. 7 shows the antiseptic cap piston assembly 12
- FIG. 8 shows the antiseptic cap equipped piston assembly 12 inserted into the chamber of the syringe barrel 14 to define the antiseptic cap equipped piston and syringe barrel assembly 10.
- FIGS. 3 and 4 show one possible method for utilizing the cap assembly 80 by docking with the access device 38.
- FIG. 3 shows the lid stock 68 pealed away from the flange 70 and
- FIG. 4 shows docking the antiseptic cap assembly 80 to the valve 39.
- the syringe barrel is rotated clockwise or counterclockwise to engage the threads 88 of the antiseptic cap assembly 80 with the threads of the access site 38. After engagement, the syringe barrel 14 will be moved away from the access site 38 and the antiseptic cap assembly 80 will slide outward from the housing 60 and remain docked to the access site 38.
- the antiseptic cap assembly 80 can remain docked to the valve 39 of the access site 38 for any suitable period of time from a few minutes to numerous hours.
- the tubing or catheter 41 is sealed to block the ingress into the catheter of pathogens and contaminants and a portion of the access site 38 is exposed to the antiseptic material in the sponge 86.
- the present invention provides a mechanism associated with the assembly 10 for preventing the rotation of the antiseptic cap assembly 80 with respect to the plunger assembly 12 and more preferably a mechanism on either the plunger assembly or on the antiseptic cap 80 to prevent relative rotational movement between the antiseptic cap 80 and the plunger assembly 12.
- the mechanism for preventing relative rotation of the antiseptic cap 80 with respect to the plunger assembly 12 has mating portions on both parts that when assembled cooperatively engage one another to prevent relative rotation. It is also contemplated that a separate mechanism, device or member could be used to lock the two parts together to achieve this purpose.
- FIGS. 5, 9-11 show exemplary structures for locking the antiseptic cap assembly 80 inside the housing 60 so that these parts rotate together and one part does not rotate in a direction or at a rate different from that of the other part.
- FIGS. 15-18 show exemplary structures for interlocking the antiseptic cap plunger assembly 12 with the syringe barrel 14.
- the housing 60 will have a feature or structure that forms an interference fit with an external surface 83 of the antiseptic cap 80. Even more preferably, an internal surface 63 of the side wall 62 of the housing 60 will have a feature or structure to form an interference fit with a portion of the antiseptic cap assembly 80.
- the antiseptic cap assembly 80 will have a feature to form an interference fit with the housing 60 and even more preferably the outer surface 83 of the antiseptic cap 80 will have a feature to contact the inner surface 63 of the housing side wall 62.
- the plunger housing 60 and the cap assembly 80 each will have a feature or structure that cooperatively engage one another to prevent relative rotation of the cap assembly 80 and the housing 60.
- FIG. 5 shows one preferred form of the invention having a plurality of circumferentially spaced and axially extending ribs 100 on the internal surface 63 of the housing side wall 62 (internal ribs 100) for engaging the wall 83 of the antiseptic cap 82 to lock the cap assembly 80 in place to prevent rotation of the cap assembly 80 when positioned inside the housing 60.
- the internal ribs 100 extend from a bottom wall 102 up to an intermediate height of the housing sidewall 62.
- the internal ribs 100 will have a height roughly equal to a height of the cap 82.
- a plurality of internal slots 108 are defined between each set of adjacent internal ribs 100.
- the internal ribs 100 in a preferred form of the invention, will have a width that tapers inwardly from proximate the bottom wall 102 to a top 104 of the internal ribs 100 so that the width of the internal ribs decrease from a bottom 106 of a rib to the top 104 of the rib. Also, it is preferable that the top of the internal ribs 100 have a generally arcuate profile to act as a lead-in during insertion of the antiseptic cap assembly 80 into the housing 60. In a preferred form of the invention, the internal ribs 100 will terminate short of a top 113 of the housing sidewall 62 to define an annular gap 111 between the top of the rib 104 and the top 113. Also, extending radially inwardly from the internal surface 63 of the cap 82 is a detent 109 positioned proximate a top portion 113 of the side wall 62.
- the antiseptic cap 82 has a plurality of circumferentially spaced and axially extending ribs 120 extending along an external surface 122 of the cap 82 (external ribs 120) from an annular flange 123.
- the external ribs 120 are dimensioned for engaging a portion of the interior wall of the housing 62 to prevent relative rotation of the cap and the plunger assembly 12 and define a plurality of external slots one of each between each adjacent pair of external ribs.
- each of the external ribs 120 are positioned within an internal slot 108 and each of the internal ribs are positioned within an external slot to lock together these parts to assure that the cap rotates in the same direction as the plunger rod.
- FIGS. 6 and 11 also show that when the cap 82 is positioned within the housing 60, the detent 109 contacts the annular flange 123 to hold the cap in the housing to prevent or resist inadvertent dropping of the cap from the housing prior to docking of the cap with the access site.
- the external ribs 120 are specifically designed in conjunction with internal slots 108 so that the antiseptic cap is guided out of the storage chamber 64 as the cap is screwed onto the threads of the access site.
- FIGS. 12- 14 show several embodiments of gripping surfaces on the housing 60 (with lid stock 68 removed) to facilitate use of the assembly 10 or the plunger assembly 12.
- FIG. 12 shows axially extending and circumferentially spaced protuberances 130 on an outer surface of the wall 62.
- the protuberances 130 can have numerous different cross- sectional shapes including circular, polygonal, oval and irregular and, in a preferred form of the invention, extend from the flange 70 to a bottom of the housing.
- FIG. 13 shows a housing 60 that has no flange 70 and has protuberances 130 on the wall 62 extending substantially the entire height of the housing 60.
- FIG. 14 shows a housing 60 where the outer surface of the wall 62 is relatively smooth but has a series of circumferentially spaced and axially extending protuberances 130 on a circumferential edge of the flange 70.
- the optional plunger assembly 12 and syringe barrel 14 locking feature or structure can be positioned alone on the plunger assembly 12, or alone on the syringe barrel 14 or have cooperating structures on both the plunger assembly 12 and the syringe barrel 14. It is also contemplated that a separate mechanism, device or member could be used to lock the two parts together to achieve this purpose.
- FIGS. 15-18 show various embodiments for the optional feature of locking the plunger assembly 12 from rotational motion with respect to the syringe barrel 14.
- a wing 150 extending axially along an outside surface of the housing side wall 62 engages a tooth 152 positioned on an interior surface of the syringe barrel at is proximal end.
- the plunger assembly 12 will have more than one wing 150 with each wing being circumferentially spaced from the other.
- the plunger assembly will have four wings 150 spaced 90 degrees from one another.
- the syringe barrel will have a plurality of circumferentially spaced teeth. When the plunger assembly is nearly fully inserted into the syringe barrel each of the wings will extend into a tooth to prevent rotation of the plunger assembly 12 with respect to the syringe barrel 14.
- FIG. 18 shows another embodiment of a locking feature to prevent rotation of the plunger assembly 12 with respect to the syringe barrel 14 and also prevents relative translational motion of the parts.
- an annular protuberance 160 positioned on an interior surface of the syringe barrel at its proximal end 20 engages an annular detent 162 on an outside surface of the plunger rod.
- FIGS. 19 and 20 show an antiseptic cap equipped plunger assembly 12 and non- refluxing syringe assembly 170.
- Non-refluxing syringes are well known in the art and there are numerous methodologies for reducing reflux while accessing the access site of a central venous catheter.
- the annular flange 70 of the plunger assembly 12 abuts the flange 24 of the syringe barrel prior to the piston 50 contacting an interior surface of the syringe distal end wall 30.
- FIGS. 22a, b show a stand-alone antiseptic cap assembly 200 having three circumferentially spaced ribs 120 for grasping by the hand of a user of the cap assembly.
- FIG. 22a shows the cap 82 without an absorbent material 86 and
- FIG. 22b shows the cap with an absorbent material.
- the cap 200 can be used for the same purposes of the cap assembly 80 described above but will be used by hand. All other features of the cap 200 are essentially the same as described above with the exception that the cap 200 does not have to be dimensioned to fit within a chamber carried by a syringe plunger.
- FIGS. 23 and 24 show varying frequency of ribs 120 and varying shapes and sizes.
- FIG. 25 shows the cap 200 proximate the access site 38 and FIGS. 26 and 27 show the cap 200 docked to the access site 38.
- a suitable absorbent material 86 includes medical grade materials capable of storing and releasing an antiseptic liquid, or liquid having other medical purposes, and includes materials such as sponges, rupturable capsules and other materials or devices capable of serving this purpose.
- Suitable sponges can include any sponge suitable for use for medical purposes and can be naturally occurring or synthetic. The sponges can be die cut into suitable shapes or can be molded into the desired shape. It is desirable that the sponge 86 be attached to the antiseptic cap 82 to prevent the sponge 86 from inadvertently falling out of the cap 82.
- FIG. 28 shows the sponge 86 is captured between an annular wall 202 and a disc 204 attached to the cap 82 by any suitable method such as ultrasonic or vibrational welding or other techniques well known in the art.
- FIGS. 29 and 30 show a variation on the cap assembly 200 of FIG. 28.
- the sponge is retained in the cap 82 with a plastic sheet 206 heat welded to the cap.
- the sponge is attached by an adhesive or by other method to form an assembly which is then attached to the cap.
- FIGS. 31 a, b show the cap 200 having a coaxially disposed and axially extending actuating post 220 circumferentially surrounded by a sponge 86 having a centrally positioned hole to fit over the post 220.
- FIG. 31a shows the cap 200 in initial engagement with the access site 38 and
- FIG. 31b shows the cap threaded onto the access site 38 and the actuating post opens the valve 39 and antiseptic fluid is allowed to flow into the valve.
- FIGS. 32-34 show varying shaped sponges that, in one preferred form of the invention, were molded into various desirable shapes.
- the sponge of FIG. 34 has a central opening 230 to facilitate attaching the sponge to the cap and to filling the sponge with antiseptic, anticoagulant or other suitable fluids set forth above.
- FIG. 35 shows the cap having a centrally disposed energy director 231, an ultrasonic welder 232 being brought into cooperative engagement with the sponge on a side of the sponge opposite the energy director 231. By applying ultrasonic energy the energy director 231 melts and attaches the sponge to the cap.
- FIG. 36 shows a filling device 240, having a lumen 242 and a dispensing head 244 in fluid communication with a source of antiseptic, anticoagulant or the like for dispensing a metered amount of such fluid into the interior portion of the sponge.
- FIG. 37 shows an alternative embodiment of the antiseptic cap 200 where the sponge is replaced by an antiseptic coating on the actuating post 220.
- FIG. 38 shows the antiseptic cap 200 positioned in a blister pack 233 prior to sealing the blister pack.
- FIG. 39 shows an antiseptic cap 300 with a thread cover 302.
- the thread cover 302 can be part of any of the antiseptic caps discussed herein.
- the thread cover 302 is made of a deformable material capable of flexing upon application of moderate force applied by hand.
- the thread cover 302 is made from a polymeric containing material and more preferably a polymeric material having a modulus of elasticity of less than 20,000 psi.
- the polymeric material will be an elastomer or plastomer or like material.
- the thread cover 302 enhances the connection between the antiseptic cap 300 and a device such as a valve or other access devices 38.
- the thread cover 302 provides a physical barrier to the ingress of pathogens, dust or other contaminants through the mating threads of the antiseptic cap 300 and the access device or valve to which it is docked.
- the thread cover 302 also serves to retain antiseptic fluids from the antiseptic cap 300 from leaking out through the threads.
- the thread cover can be made a part of the antiseptic cap 300 using techniques well known in the art such as overmolding, or by attaching as a separate part using welding techniques such as heat conductive welding, heat induction welding, vibrational welding, stretch or friction fit, or by using a suitable adhesive.
- the thread cover 302 can provide a universal fit to most commercially available valves, connectors and access devices, or the thread cover 302 can be customized to dock with a particular access device.
- FIG. 39 shows, as is described above, the antiseptic cap 300 has an annular wall
- the annular wall defines a central chamber 322 having an open end 323.
- the chamber 322 will have a sponge 86 positioned therein as shown in FIG. 5 and 6 above, although it is not shown in FIG. 39.
- the thread cover 302 is shown attached by an optional bonding layer 304 to the first end 306 of the annular wall 305.
- the thread cover 302 has a first leg 308 and a second leg 310.
- the first leg 308 extends parallel to the annular wall 305 and the second leg 310 extends radially inwardly from the annular wall 305 in a direction transverse to the first leg 308 and across a portion of the open end 323 and defines a central opening 312, having a reduced diameter when compared to the open end 323, into the chamber 322.
- the second leg 310 terminates at a distal end 330 with a rounded outer surface 332.
- FIG. 40 shows an alternative embodiment of the antiseptic cap 300 having the thread cover 302 having both the first and second legs 308, 310 attached to the first end
- a top surface 340 of the first end 306 is shown having the same thickness or diametrical dimension as the remainder of the first end but it is contemplated the top surface could have a radially extending flange 123 as shown in FIG. 5.
- FIG. 41 shows an alternative embodiment of the antiseptic cap 300 that differs from the antiseptic cap shown in FIGS. 39 and 40 by not including a counterbore 336 shown in these figures.
- the counterbore 336 provides a chamber of reduced diameter and, therefore, will form a tighter fit with access devices with a narrower outer diameter when compared to the cap shown in FIG. 41 which does not include the counterbore.
- This is just one example of the modifications that can be made to the geometry of the antiseptic cap to enhance the connection between the cap and an access site.
- FIGS. 42a,b show front and back views of the antiseptic cap 300 with the thread cover 302 connected to a Cardinal SMART SITE access site 350.
- FIGS. 43 a,b are perspective front and back views of the antiseptic cap without the thread cover 302 connected to the Cardinal SMART SITE access site.
- FIGS. 44a,b are perspective front and back views of the antiseptic cap 300 with the thread cover 302 connected to a Hospira (ICU) CI 000 Clave access device 352.
- FIGS. 45a,b are perspective front and back views of the antiseptic cap, without a thread cover 302, connected to the Hospira (ICU) CI 000 Clave access device.
- FIGS. 46a,b are perspective front and back views of the antiseptic cap 300 with the thread cover 302 connected to a B. Braun ULTRASITE access device 354.
- FIGS. 47a,b are perspective front and back views of the antiseptic cap without the thread cover 302 connected to the B. Braun ULTRASITE access device.
- FIGS. 48a,b are perspective front and back views of the antiseptic cap with the thread cover 302 connected to a Rymed I VISION PLUS access device; 356.
- FIGS. 49a,b are perspective front and back views of the antiseptic cap without the thread cover 302 connected to a Rymed INVISION PLUS access device.
- FIGS. 50-52 show various embodiments of the thread cover 302.
- FIG. 50 differs from FIG. 51 in that the second leg 310 extends farther across the opening of the chamber in FIG. 51 than shown in FIG. 50.
- FIG. 52 shows another embodiment of the thread cover 302 having a segmented second leg 310a,b. This embodiment may be desirable to provide a more effective seal for certain access devices.
- FIG. 53 shows an exploded view of an alternative embodiment 400 of the syringe barrel assemblies 10, discussed above, incorporating a cap holder 402 into the system of parts.
- the alternative assembly and system 400 has an antiseptic cap and cap holder equipped plunger assembly 12', a syringe barrel 14, an antiseptic cap 82 (shown with an optional thread cover 302), an absorbent material 86, and peelable lid stock 68.
- FIG. 54 shows an exploded view of an antiseptic cap holder assembly 404 including the cap holder 402 with the antiseptic cap assembly 80 positioned within a chamber 406 of the cap holder 402.
- This embodiment 400 allows for the separate manufacture, assembly, and sterilization of the assembly 400 from the plunger assembly and the syringe barrel.
- the cap holder 402 has a proximal and distal ends 408, 410, and an inner wall surface 412 and an outer wall surface 414, an opening 416 into the chamber 406, and a radially outwardly extending flange 418 circumjacent the opening 416 and extending from the proximal end 408 of the cap holder 402.
- the cap holder 402 will also have an optional bottom wall 419.
- the cap holder 402 or the antiseptic cap 82 will have a structure, element or the like that prevents the relative rotation of the cap holder 402 and the antiseptic cap 82 until the antiseptic cap assembly 80 is securely docked to the access device 38.
- the cap holder 402 or the plunger assembly 12' will have a structure, element or the like for preventing the relative rotation of the cap holder 402 and the plunger assembly 12' until the antiseptic cap assembly 80 is securely docked to the access device 38. Any of the anti-rotation devices discussed above to stop the rotation of the antiseptic cap assembly 80 with the plunger assembly 12 would be suitable for, these purposes. Also, it is contemplated the devices discussed above in reference to FIGS. 15-21 to prevent the relative rotation of the plunger assembly 12 and the syringe barrel 14 could be incorporated into this embodiment 400.
- FIG. 53 shows the inner wall surface 412 of the cap holder 402 carries the internal ribs 100 and the internal slots 108 that interact with the external ribs and external slots 120, 122 of the cap 82 as is described above with respect to FIG. 5. These structures prevent or resist the relative rotation of the cap holder 402 with respect to the antiseptic cap assembly 80.
- ribs referred to herein are structures that are raised or extend outward from a surface.
- slots refer to structures that extend below a surface or is defined between two ribs and is at a lower level than the ribs.
- FIG. 53 also shows an interlocking structure for preventing the relative rotation of the cap holder 402, or the cap holder assembly 404, with respect to the plunger assembly 12'.
- the outer wall surface 414 has a plurality of circumferentially spaced and axially extending ribs 420 defining slots 424 between each pair of adjacent ribs.
- the ribs 420 are generally triangular in shape having a base portion 426 and an apex portion 428.
- the slots 424 are oppositely-oriented triangularly shaped areas having slot base portions 430 extending between two adjacent rib apex portions 428 and slot apex portions 432 separating adjacent rib base portions 426.
- plunger ribs 434 and plunger slots 436 On the internal wall surface 63 of the plunger chamber 64 are similarly shaped plunger ribs 434 and plunger slots 436.
- the ribs 420 are dimensioned to fit within the plunger slots 436 and the slots 424 are dimensioned to fit over and receive the plunger ribs 434.
- the cap holder 402 the cap holder assembly 404 or the plunger assembly 12' will have a structure, element or the like that resists the relative axial movement of these parts when the cap holder 402 or the cap holder assembly 404 is positioned fully within the plunger assembly 12'.
- the cap holder 402 has an annular protuberance 440 that is dimensioned to fit within an annular groove 442 on the inner wall surface 414 of the cap holder and preferably extends in line with the base portions of the plunger ribs 434.
- a second locking structure is provided having a plurality of teeth 450 which extend axially outward from the outer wall surface 414 of the cap holder and are positioned in slots 424.
- the teeth extend axially outwardly to a height beyond the height of the ribs 434.
- the teeth 450 can be positioned in one or more of the slots or in each of the slots 424 or in alternating slots or, as is shown, circumferentially spaced 90° from one another.
- the teeth 450 preferably are positioned at an intermediate portion, between the base and the apex, of a slot 424.
- the teeth 450 are dimensioned to fit within a segmented annular groove 452 that extends circumferentially about the inner surface 412 crossing through the plunger ribs 434 at an intermediate portion, between the base and the apex, of the plunger ribs 434.
- FIGS. 56a,b,c respectively show the assembly 400 in a ready-for-use position, docked position, and used position.
- the assembly 400 is used in essentially the same fashion as described above with respect to FIGS. 3 and 4 except that when the assembly 400 is in the used position the cap holder 402 remains in the plunger assembly 12'.
- the syringe barrel and plunger can be fabricated from any material suitable for its purpose and includes glass and polymeric material.
- Suitable polymeric materials include, but are not limited to, homopolymers, copolymers and terpolymers formed from monomers such as olefins, cyclic olefins, amides, esters, and ethers.
- the polymeric material may be a blend of more than one polymeric material and can be a monolayer structure or a multilayer structure.
- the syringe barrel and the plunger are injection molded from a polypropylene material.
- the third embodiment 500 provides for retrofitting an antiseptic cap assembly 502 to a standard plunger 504.
- the antiseptic cap 502 has a first generally cylindrical outer wall 506 having a proximal end 508 and a distal end 510.
- the proximal end 508 is removably or fixedly attached to a button 512 of the plunger 504.
- the proximal end has an opening 514 dimensioned to fit about the button 512 and has a member for attaching to the button.
- the attaching member includes a plurality of circumferentially spaced, and axially inwardly directed tabs 516 extending from an inner wall surface 518 and the tabs engage a lower surface of the button 512 to attach the antiseptic cap assembly 502 to the plunger 504.
- the distal end of the antiseptic cap 502 has a top annular flange 520 extending radially inwardly from the first cylindrical wall 506 and defines a generally circular opening 522.
- a second cylindrical wall 524 extends axially downwardly from the top annular flange 520 and is coaxially disposed within the first cylindrical wall 506.
- a second set of tabs could be provided spaced axially away from the first set of tabs and the piston button 512 could be trapped between the two sets of tabs.
- attaching means could be used that are well know in the art and the attaching member shown is merely exemplary.
- the second cylindrical wall 524 defines a chamber as is shown in greater detail in FIG. 5 above with the ribs and slots as described for engaging the antiseptic cap assembly 80 to prevent relative rotational movement and to resist relative axial movement of the parts when the antiseptic cap assembly 80 is fully inserted into the chamber. Further, it is contemplated adapting the plunger and syringe as described above to prevent or resist the relative rotational movement of the plunger with respect to the barrel.
- the piston 50 can be formed from any suitable material including a polymeric material or a silicone material.
- the stopper can be selected from a material with a desired durometer so that reflux is reduced when the stopper engages an inner surface of the distal end wall of the syringe barrel.
- Suitable locking and flush solutions include a lower alcohol selected from ethanol, propanol and butanol.
- the locking solution can be a single lower alcohol or a blend of lower alcohols.
- Suitable locking solutions can also include a lower alcohol with an antimicrobial and or an anticoagulant.
- Suitable locking solutions can contain at least one lower alcohol in a range from 1% to 99% by volume and at least one other anti-microbial and/or anticoagulant compound in a range from 1% to 99% by volume.
- the lower alcohol will usually be in aqueous solution, typically at 1% to 99% by volume, usually from 5% to 95% by volume.
- the at least one other anti-microbial is selected from the group consisting of taurolidine and triclosan
- the at least one anti-coagulant is selected from the group consisting of riboflavin, sodium citrate, ethylene diamine tetraacetic acid, and citric acid.
- the syringe assembly 10 will be pre-filled with one of the locking solutions and will be packaged by a manufacture and shipped to a health care provider.
- a cannula or needle will be attached to the distal end of the barrel and placed into fluid communication with the fluid access site of an indwelling central venous catheter.
- the flush solution will be injected into the catheter to clean or lock the catheter.
- the cap assembly 80 will be removed from the plunger 17 and the cap will be docked to the fluid access site of the catheter.
- the antiseptic is a solution a citrate salt and in another form of the invention the citrate salt solution is a hypertonic solution.
- hypertonic is used herein to refer to a fluid having an osmotic concentration and a density greater than the osmotic concentration and density of the blood of the patient.
- the antiseptic solution preferably comprises a citrate salt with a concentration range, in weight percent, of from about 1.5% to about 50% with an osmolality of about 300 to about 6400 mOsm. More preferably, the antiseptic solution comprises citrate salt in a concentration range of from about 10% to about 40%, yet more preferably, in a concentration range of from about 20% to about 30%.
- the antiseptic solution is prepared to have a pH lower than that of the pH of the patient's blood.
- the citrate salt solution may be prepared to have a pH lower than about 6.5, more preferably, from about 4.5 to about 6.5.
- the citrate salt solution can include pharmaceutically acceptable agents such as sodium chloride and sodium heparin.
- the citrate salt solution can also include a variety of other antibacterial, antimicrobial and anticoagulant agents such as gentamicin, vancomycin, and mixtures of these agents. Additional anticoagulant agents include, for example heparin, urokinase, tissue plasminogen activation (tPA) and mixtures of these agents.
- citrate salt solution and the included salts and other additives which are, within the scope of sound medical judgment, suitable for use in contact with tissues of humans and lower animals without undue toxicity, irritation, and allergic response. It is also typically necessary that a composition be sterilized to reduce the risk of infection.
- An antimicrobial agent containing antiseptic solution of the present invention may contain at least one alcohol, at least one antimicrobial agent and at least one chelator and/or anticoagulant.
- Various antimicrobial substances as disclosed herein and that are well known to one of ordinary skill in the art may be combined with the locking solution in order to inhibit infection.
- the antimicrobial locking solution of the present invention may be use for filling or flushing a medical device such as an indwelling device such as an implanted catheter. Other medical devices that are contemplated for use in the present invention are disclosed herein.
- the antiseptic agent can contain antibacterial agents such as those classified as aminoglycosides, beta lactams, quinolones or fluoroquinolones, macrolides, sulfonamides, sulfamethaxozoles, tetracyclines, treptogramins, oxazolidinones (such as linezolid), clindamycins, lincomycins, rifamycins, glycopeptides, polymxins, lipo-peptide antibiotics, as well as pharmacologically acceptable sodium salts, pharmacologically acceptable calcium salts, pharmacologically acceptable potassium salts, lipid formulations, derivatives and/or analogs of the above.
- antibacterial agents such as those classified as aminoglycosides, beta lactams, quinolones or fluoroquinolones, macrolides, sulfonamides, sulfamethaxozoles, tetracyclines, tre
- the aminoglycosides are bactericidal antibiotics that bind to the 3 OS ribosome and inhibit bacterial protein synthesis. They are typically active against aerobic gram-negative bacilli and staphylococci. Exemplary aminoglycosides that may be used in some specific aspects of the invention include amikacin, kanamycin, gentamicin, tobramycin, or netilmicin.
- Suitable beta lactams are selected from a class of antibacterials that inhibit bacterial cell wall synthesis.
- a majority of the clinically useful beta-lactams belong to either the penicillin group (penam) or cephalosporin (cephem) groups.
- the beta-lactams also include the carbapenems (e.g., imipenem), and monobactams (e.g., aztreonam).
- Inhibitors of beta- lactamase such as clavulanic acid and its derivatives are also included in this category.
- Non-limiting examples of the penicillin group of antibiotics that may be used in the solutions of the present invention include amoxicillin, ampicillin, benzathine penicillin G, carbenicillin, cloxacillin, dicloxacillin, piperacillin, or ticarcillin, etc.
- cephalosporins examples include ceftiofur, ceftiofur sodium, cefazolin, cefaclor, ceftibuten, ceftizoxime, cefoperazone, cefuroxime, cefprozil, ceftazidime, cefotaxime, cefadroxil, cephalexin, cefamandole, cefepime, cefdinir, cefriaxone, cefixime, cefpodoximeproxetil, cephapirin, cefoxitin, cefotetan etc.
- beta lactams include mipenem or meropenem which are extremely active parenteral antibiotics with a spectrum against almost all gram-positive and gram-negative organisms, both aerobic and anaerobic and to which Enterococci, B.fragilis, and P. aeruginosa are particularly susceptible.
- Suitable beta lactamase inhibitors include clavulanate, sulbactam, or tazobactam.
- the antibacterial solutions may comprise a combination of at least one beta lactam and at least one beta lactamase inhibitor.
- Macrolide antibiotics are another class of bacteriostatic agents that bind to the 5 OS subunit of ribosomes and inhibit bacterial protein synthesis. These drugs are active against aerobic and anaerobic gram-positive cocci, with the exception of enterococci, and against gramnegative anaerobes. Exemplary macrolides include erythromycin, azithromycin, clarithromycin.
- Quinolones and fluoroquinolones typically function by their ability to inhibit the activity of DNA gyrase. Examples include nalidixic acid, cinoxacin, trovafloxacin, ofloxacin, levofloxacin, grepafloxacin, trovafloxacin, sparfloxacin, norfloxacin, ciprofloxacin, moxifloxacin and gatifloxacin.
- Sulphonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. These drugs inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Examples include mafenide, sulfisoxazole, sulfamethoxazole, and sulfadiazine.
- the tetracycline group of antibiotics include tetracycline derivatives such as tigecycline which is an investigational new drug (IND), minocycline, doxycycline or demeclocycline and analogs such as anhydrotetracycline, chlorotetracycline, or epioxytetracycline .
- Suitable streptogramin class of antibacterial agents include quinupristin, dalfopristin or the combination of two streptogramins.
- Drugs of the rifamycin class typically inhibit DNA-dependent RNA polymerase, leading to suppression of RNA synthesis and have a very broad spectrum of activity against most gram-positive and gram-negative bacteria including Pseudomonas aeruginosa and Mycobacterium species.
- An exemplary rifamycin is rifampicin.
- antibacterial drugs are glycopeptides such as vancomycin, teicoplanin and derivatives thereof.
- antibacterial drugs are the polymyxins which are exemplified by colistin.
- antibacterial agents such as prestinomycin, chloramphenicol, trimethoprim, fusidic acid, metronidazole, bacitracin, spectinomycin, nitrofurantion, daptomycin or other leptopeptides, oritavancin, dalbavancin, ramoplamin, ketolide etc. may be used in preparing the antiseptic solutions described herein.
- metronidazole is active only against protozoa, such as Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis, and strictly anaerobic bacteria.
- Spectinomycin is a bacteriostatic antibiotic that binds to the 3 OS subunit of the ribosome, thus inhibiting bacterial protein synthesis and nitrofurantoin is used orally for the treatment or prophylaxis of UTI as it is active against Escherichia coli, Klebsiella-Enterobacter species, staphylococci, and enterococci.
- the antimicrobial agent is an antifungal agent.
- Some exemplary classes of antifungal agents include imidazoles or triazoles such as clotrimazole, miconazole, ketoconazole, econazole, butoconazole, omoconazole, oxiconazole, terconazole, itraconazole, fluconazole, voriconazole, posaconazole, ravuconazole or flutrimazole; the polyene antifungals such as amphotericin B, liposomal amphoterecin B, natamycin, nystatin and nystatin lipid formulations; the cell wall active cyclic lipopeptide antifungals, including the echinocandins such as caspofungin, micafiingin, anidulfungin, cilofungin; LY121019; LY303366; the allylamine group of antifungals such as terbinafine.
- antifungal agents include naftifine, tolnaftate, mediocidin, candicidin, trichomycin, hamycin, aurefungin, ascosin, ayfattin, azacolutin, trichomycin, levorin, heptamycin, candimycin, griseofulvin, BF-796, MTCH 24, BTG- 137586, pradimicins ( NS 18184), benanomicin; ambisome; nikkomycin Z; flucytosine, or perimycin.
- the antimicrobial agent is an antiviral agent.
- Non-limiting examples of antiviral agents include cidofovir, amantadine, rimantadine, acyclovir, gancyclovir, pencyclovir, famciclovir, foscamet, ribavirin, or valcyclovir.
- the antimicrobial agent is an innate immune peptide or proteins.
- Some exemplary classes of innate peptides or proteins are transferrins, lactoferrins, defensins, phospholipases, lysozyme, cathelicidins, serprocidins, bacteriocidal permeability increasing proteins, amphipathic alpha helical peptides, and other synthetic antimicrobial proteins.
- the antimicrobial agent is an antiseptic agent.
- antiseptic agents include a taurinamide derivative, a phenol, a quaternary ammonium surfactant, a chlorine-containing agent, a quinaldinium, a lactone, a dye, a thiosemicarbazone, a quinone, a carbamate, urea, salicylamide, carbanilide, a guanide, an amidine, an imidazoline biocide, acetic acid, benzoic acid, sorbic acid, propionic acid, boric acid, dehydroacetic acid, sulfurous acid, vanillic acid, esters of p-hydroxybenzoic acid, isopropanol, propylene glycol, benzyl alcohol, chlorobutanol, phenylethyl alcohol, 2-bromo-2-nitropropan-l,3-diol, formaldehyde, glutaral
- the antiseptic solution includes a basic reagent and a dye.
- the basic reagent may be a guanidium compound, a biguanide, a bipyridine, a phenoxide antiseptic, an alkyl oxide, an aryl oxide, a thiol, a halide, an aliphatic amine, or an aromatic amine.
- the basic reagent is a guanidium compound.
- Non- limiting examples of guanidium compounds include chlorhexidine, alexidine, hexamidine.
- the basic reagent is a bipyridine.
- One example of a bipyridine is octenidine.
- the basic reagent is a phenoxide antiseptic.
- the dye may be a triarylmethane dye, a monoazo dye, a diazo dye, an indigoid dye, a xanthene dye, an anthraquinone dye, a quinoline dye, an FD&C dye.
- triarylmethane dye include gentian violet, crystal violet, ethyl violet, or brilliant green.
- Exemplary monoazo dyes include FD&C Yellow No. 5, or FD&C Yellow No. 6.
- Other non-limiting examples of FD&C dye include Blue No. 1 or Green No. 3.
- One non-limiting example of diazo dyes is D&C Red No. 17.
- An example of an indigoid dye is FD&C Blue No. 2.
- An example of a xanthene dye is FD&C Red No. 3; of an anthraquinone dye is D&C Green No. 6; and of an quinoline dye is D&C Yellow No. 1.
- antiseptic agents that may be used to prepare the amntimicrobial solutions of the invention are gendine, genlenol, genlosan, or genfoctol.
- antimicrobial agents including one or more antibacterial agent, and/or one or more antifungal agent, and/or one or more antiviral agent, and/or one or more antiseptic agent, and/or combinations thereof.
- chelator agents are contemplated as useful in preparing the antiseptic solutions of the invention. This includes chelators such as EDTA free acid, EDTA 2Na, EDTA. 3Na, EDTA 4Na, EDTA 2K, EDTA 2Li, EDTA 2NH 4 , EDTA 3K, Ba(II)-EDTA, Ca(II)-EDTA, Co(II)-EDTACu(II)-EDTA, Dy(III)-EDTA, Eu(III)-EDTA, Fe(III)-EDTA, In(III-EDTA, La(III)-EDTA, CyDTA, DHEG, diethylenetriamine penta acetic acid (DTPA), DTPA-OH, EDDA, EDDP, EDDPO, EDTA-OH, EDTPO, EGTA, HBED, HDTA, HIDA, IDA, MethylEDTA, NTA, NTP, NTPO, O-Bistren, TT
- at least one anticoagulant such as heparin, hirudin, EGTA, EDTA, urokinase, streptokinase, hydrogen peroxide etc.
- at least one anticoagulant such as heparin, hirudin, EGTA, EDTA, urokinase, streptokinase, hydrogen peroxide etc.
- an anticoagulant such as heparin, hirudin, EGTA, EDTA, urokinase, streptokinase, hydrogen peroxide etc.
- a variety of alcohols are contemplated as useful in the preparation of the instant antiseptic solution, and include any antimicrobially active alcohol.
- the solutions of the instant invention can comprise various combinations of at least one alcohol, at least one antimicrobial agent, and at least one chelator/anticoagulant.
- the solution of the invention comprises at least one alcohol, at least one tetracycline and at least one chelator/anticoagulant.
- such an antimicrobial solution comprises ethanol, at least one tetracycline and EDTA or heparin.
- such a solution comprises ethanol, minocycline and EDTA or heparin.
- the concentration of minocycline is 0.001 mg/ml to 100 mg/ml.
- the concentration of minocycline is about 3 mg/ml.
- the concentration of EDTA is in the range of 10-100 mg/ml. In one embodiment of this aspect, the concentration of EDTA is about 30 mg/ml.
- the antiseptic solution includes a pharmacologically acceptable sodium salt, a pharmacologically acceptable calcium salt, a pharmacologically acceptable potassium salt and about one milligram per milliliter polyhexamethylene biguanide hydrochloride in an aqueous admixture.
- the solution of the invention may also contain a pharmacologically acceptable salt of lactic acid.
- One preferred antiseptic solution includes a pharmacologically acceptable sodium salt such as sodium chloride or the like in a concentration of between about 820 mg to about 900 mg, a pharmacologically acceptable calcium salt, such as calcium chloride dihydrate or the like in a concentration between about 30.0 mg to about 36.0 mg, a pharmacologically acceptable potassium salt, such as potassium chloride or the like in a concentration between about 28.5 to about 31.5 mg and about one milligram per milliliter polyhexamethylene biguanide hydrochloride in an aqueous admixture with one hundred milliliters of water for injection U.S.P.
- the solution of the invention may also include sodium lactate in a concentration between about 290 mg and about 330 mg in the one hundred milliliter aqueous admixture.
- the antiseptic solution contains an anticoagulant and a photo-oxidant.
- a photo-oxidant is selected that has an antiseptic effect.
- photo-oxidant is intended to refer to a compound (usually an organic dye) that has photo-oxidation properties, in which the compound exhibits an increased oxidizing potential upon exposure to radiant energy such as light.
- photooxidant also refers to a composition that releases one or more electrons when struck by light.
- the photo-oxidant is methylene blue, which advantageously provides antibiotic and antifungal activity, and also provides a color to make the antiseptic solution clearly identifiable.
- other photo-oxidants may include Rose Bengal, hypericin, methylene violet, proflavine, rivanol, acriflavine, toluide blue, trypan blue, neutral red, a variety of other dyes or mixtures thereof. Therefore, in alternate aspects of the invention, one or more alternative photo- oxidants, preferably a colored photo-oxidant is used in accordance with the invention in place of methylene blue.
- the antiseptic solution includes a low viscosity antibacterial agent mixed with a viscosity increasing agent.
- antibacterial agents which may be used, in addition to those described above, comprise alcohols, chlorhexidine, Chlorpactin, iodine, tauroline, citric acid, and soluble citric acid salts, particularly sodium citrate, optionally mixed with water.
- Suitable viscosity increasing agents include Carbopol, starch, methylcellulose, carboxypolymethylene, carboxymethyl cellulose, hydroxypropylcellulose, or the like.
- Carbopol is a cross-linked polyacrylic acid based polymer sold by Noveon, Inc. It is preferably neutralized to about pH 7 with a base material such as tetrahydroxypropyl ethylene diamine, triethanolamine, or sodium hydroxide.
- Derivatives of starch may also be used, such as hydroxyethylstarch, hydroxypropylstarch, or starch having bonded organic acid ester groups, to improve compatibility with antibacterial agents such as alcohols, for example, ethanol or isopropanol.
- ester groups may be the reaction product of two to twelve carbon organic acids with the starch, for example.
- the elevated viscosity antiseptic solution may be created by the use of a fat emulsion, or other dispersions in water/alcohol of glycerol mono or di esters of fatty acids, or fatty acid esters of other polyols such as sugars having one or more bonded fatty acid groups per molecule. Analogous compounds with ether linkages may also be used.
- the fluid of this invention may also contain an effective amount of an antithrombogenic agent such as heparin, and a diluent such as water, along with other desired ingredients.
- an antithrombogenic agent such as heparin
- a diluent such as water
- the antiseptic solution contains a mixture of isopropyl alcohol and neutralized Carbopol, with other optional ingredients being present such as water, antithrombogenic agents such as heparin, and the like. Preferably, about 0.4 to 2 weight percent of Carbopol is present.
- Citric acid may also be present as an antibacterial agent, either with or as a substitute for another anti-bacterial agent such as isopropyl alcohol or ethanol.
- the antiseptic solution is a gel of an isopropyl alcohol, optionally with up to about 30 weight percent water, and about 2.2 weight percent hydroxypropylcellulose, to form a high viscosity antiseptic solution.
- the antiseptic solution contains carbohydrates and/or glucose degradation products.
- Suitable carbohydrates are chosen form the group of glucose and/or fructose.
- Suitable degradation products include 3- deoxyglucosone (3-DG), acetaldehyde, formaldehyde, acetaldehyde, glyoxal, methylglyoxal; 5-hydroxymethyl-2- furaldehyde (5-HMF), 2-furaldehyde, and 3,4- dideoxyglucosone-3-ene (3,4-DGE).
- suitable agents to be used in this embodiment of the antiseptic solution includes substances having anticoagulatory properties i.e., inhibitors of the coagulation cascade such as heparin of standard and low molecular weight, fractionated heparin, synthetic inhibitors in the coagulation cascade, Futhan as a broad protease inhibitor, complexing and chelating substances such as citrate, EDTA, EGTA, substances and mixtures used for preservation of blood products (platelets or plasma), CDPA (citrate, sodium phosphate, dextrose, adenine), synthetic or natural thrombin inhibitor substances.
- suitable additives include fucosidan, riboflavin, vitamin E, alphatocopherol, folic acid and amino acids.
- antiinflammatory compounds and drugs could also be used, e.g. cortison, mycophenolic acid (MP A) and derivates thereof, sirolimus, tacrolimus and cyclosporin, diclofenac, etc.
- Inhibitory peptides can also be used in the antiseptic solution such as defensins, (dermacidine), and others.
- Radicals such as reactive oxygene species, NO-releasing systems or nitric oxide (NO), and peroxynitrite may also be used.
- a buffer composition may also be included in the antiseptic solution, and in one preferred form of the invention, the buffer contains lactate, bicarbonate, pyruvate, ethyl pyruvate and citric acid in combination and mixtures including adjustment of pH by acetic acid, hydrochloric acid or sulphuric acid.
- viscosity enhancing additives may be added, such as lipids or lipidic substances (also to get water insoluble vitamins or complexes into solution), nutrients in high concentration density gradient e.g. aminoacid containing fluids, polyglucose, lcodextrin, pectine, hydroxyethyl starch (HES), alginate, hyaluronic acid, etc.
- the antiseptic solutions of the present invention can include Taurolidine and/or Taurultam to prevent clotting and Biofilm formation or the elements can be combined with other antimicrobial agents.
- One embodiment of the present invention is a gel with thixotropic properties to keep the solution inside the antiseptic cap and not spill out during the time interval between uses. This is accomplished by making a hydrogel matrix as a drug delivery vehicle containing a biocompatible antimicrobial agent alone or with another active agent, which may be useful for particular purposes.
- the hydrogel matrix is biocompatible and, biodegradable in the bloodstream.
- the matrix can be a hydrogel (e.g., pectin, gelatin, etc), a protein (e.g., collagen, hemoglobin, etc), a colloidal substance (e.g., serum albumin etc.), an emulsion or other adjuvant.
- the matrix shall have structural integrity and be thixotropic.
- Thixotropy is a property, which is exhibited by certain gels. It is a property characterized by a solid or semisolid substance that when shaken, stirred or subject to high shear forces becomes fluid like and can flow and then returns to the semisolid state when the forces and/movement are stopped.
- the gel could have the properties similar to that of the colloidal dispersion which resists movement, or flow until a high shear force is imparted to the fluid and then it flows easily.
- the preferred antimicrobial is Taurolidine, which can be added to the matrix as a micro particle powder, or encapsulated in liposomes, microspheres, or nanospheres.
- Taurolidine can be added to the matrix as a micro particle powder, or encapsulated in liposomes, microspheres, or nanospheres.
- active agents and drugs can be added to the thixotropic gel including sterileants, lysing agents (such as Urokinase), imaging enhancers, catheter surface modifiers, antibiotics and antimicrobial chemicals.
- a hydrogel comprises a three-dimensional molecular network containing large quantities of water giving them good biocompatibility with material consistency that is soft solid-like with high diffusive properties to gases, chemicals and proteins.
- Suitable hydrogels include natural polymers including serum albumin, collagen, or alginates, polyvinyl alcohol, poly (ethylene oxide) or poly (hydroxyethylene) and polyelectrolytes, such as poly(acrylic acid), poly(styrene sulfonate), and carboxymethylcellulose (CMC).
- natural polymers including serum albumin, collagen, or alginates, polyvinyl alcohol, poly (ethylene oxide) or poly (hydroxyethylene) and polyelectrolytes, such as poly(acrylic acid), poly(styrene sulfonate), and carboxymethylcellulose (CMC).
- One preferred form of the antiseptic solution includes Taurolidine with Salicylic acid or Sodium Salicylate in an aqueous solvent.
- Salicylic Acid and Sodium Salicylate are drugs that have been used with antibiotic locks in catheters to enhance the biocidal action of the antibiotic alone and to inhibit the attachment of microbes to surfaces. This last attribute is especially important because the initiation of a Biofilm expression and growth require that the individual bacteria must first attach themselves to the underlying surface. By stopping attachment, Biofilm formation is blocked.
- Sodium salicylate has been demonstrated to have remarkable antibacterial activity, including the ability to enhance the activities of certain antibiotics. This drug inhibits adherence, growth and Biofilm formation.
- an antiseptic solution of the present invention provides antimicrobial, antifungal, anti-viral and anti-amoebic properties and may also serve as an anti -coagulant.
- Specified salts and compositions of ethylene diamine tetraacetic acid (EDTA) (CioHi 2 N 2 Na40 8 ) are used at specified concentrations and pH levels.
- antiseptic solutions of the present invention are safe for human administration and are biocompatible and non-corrosive. They may also have anticoagulant properties and are thus useful for preventing and/or treating a variety of catheter-related infections.
- antiseptic solutions of the present invention have at least four, and preferably at least five, of the following properties: anticoagulant properties; inhibitory and/or bactericidal activity against a broad spectrum of bacteria in a planktonic form; inhibitory and/or fungicidal activity against a spectrum of fungal pathogens; inhibitory and/or bactericidal activity against a broad spectrum of bacteria in a sessile form; inhibitory activity against protozoan infections; inhibitory activity against Acanthamoeba infections; safe and biocompatible, at least in modest volumes, in contact with a patient; safe and biocompatible, at least in modest volumes, in a patient's bloodstream; and safe and compatible with industrial objects and surfaces.
- the antiseptic solution can have a pH higher than physiological pH such as a pH of >
- the antiseptic solution contain a sodium EDTA salt (or combination of sodium salts) in solution at a pH in the range between 8.5 and 12.5 and, in another embodiment, at a pH of between 9.5 and 11.5 and, in yet another embodiment, at a pH of between 10.5 and 11.5.
- a sodium EDTA salt or combination of sodium salts
- EDTA salt may refer to a single salt, such as a di- sodium or tri-sodium or tetra-sodium salt, or another EDTA salt form, or it may refer to a combination of such salts.
- the composition of EDTA salt(s) depends both on the EDTA salts used to formulate the composition, and on the pH of the composition.
- the sodium EDTA salts are predominantly present in both the tri- sodium and tetra-sodium salt forms.
- the antiseptic solution contains a combination of at least the tri-sodium and tetra-sodium salts of EDTA, and more preferably solutions containing at least 10% of the EDTA in the composition is present in the tetra-sodium salt form. In yet another embodiment, at least 50% and, more preferably at least 60%, of the EDTA in the composition is present in the tri-sodium salt form.
- EDTA solutions of the present invention are preferably provided in a sterile and non-pyrogenic form and may be packaged in any convenient fashion.
- the compositions may be prepared under sterile, aseptic conditions, or they may be sterilized following preparation and/or packaging using any of a variety of suitable sterilization techniques.
- desired antiseptic solutions of the present invention are formulated by dissolving one or more EDTA salt(s) in an aqueous solvent, such as purified water, to the desired concentration and adjusting the pH of the EDTA salt solution to the desired pH.
- the antiseptic solution may then be sterilized using conventional means, such as autoclaving, UV irradiation, filtration and/or ultrafiltration, and other means.
- the preferred osmolarity range for EDTA solutions is from 240-500 mOsM/Kg, more preferably from 300-420 mOsrn/Kg.
- the solutions are preferably formulated using USP materials.
- Antiseptic solutions containing sodium salts of EDTA other than tri- and tetra- sodium salts, such as di-sodium EDTA, is also contemplated.
- di-sodium EDTA solutions can be used but such solutions have a lower pH in solution than the desired pH range of compositions of the present invention but, upon pH adjustment to the desired range using a pH adjustment material, such as sodium hydroxide, sodium acetate, and other well-known pH adjustment agents, EDTA solutions prepared using di-sodium salts are converted to the preferred combination di- and/or tri- and/or tetra-sodium salt EDTA solutions of the present invention.
- antiseptic compositions consisting of a mixture of primarily tri-and tetra- sodium EDTA is provided by dissolving di-sodium EDTA in an aqueous solution, 3%-5% on a weight/volume basis, and adding sodium hydroxide in a volume and/or concentration sufficient to provide the desired pH of>8.5 and ⁇ 12.0.
- Antibacterial enzyme refers to any proteolytic, pore-forming, degradative or inhibitory enzyme that kills or damages a bacterial species or particular strain thereof. The result may be achieved by damaging the cell wall of the bacteria, disrupting cell membranes associated with the cell wall or within the bacteria, inhibiting protein synthesis within the bacteria, disrupting the sugar backbone, or by any other mechanism attributed to a peptide or protein considered by those skilled in the art to be an antibacterial enzyme.
- the enzyme may be a natural, wild-type enzyme, modified by conventional techniques, conjugated to other molecules, recombinantly expressed, or synthetically constructed.
- Lysostaphin is important because it is effective in the treatment of staphylococci and biofilms formed therefrom.
- Lysostaphin and "lysostaphin analogues” are defined as including lysostaphin (wild type), any lysostaphin mutant or variant, any recombinant, or related enzyme (analogue) or any synthetic version or fragment of lysostaphin (whether synthetic or otherwise) that retains the proteolytic ability, in vivo and in vitro, to cleave the cross-linked polyglycine bridges in the cell wall peptidoglycan of staphylococci.
- the enzymes may be generated by post-translational processing of the protein (either by enzymes present in a producer strain or by means of enzymes or reagents introduced at any stage of the process) or by mutation of the structural gene. Mutations may include site deletion, insertion, domain removal and replacement mutations.
- the lysostaphin may be synthetically constructed, expressed in mammalian cells, insects, bacteria, yeast, reptiles or fungi, recombinantly expressed from a cell culture or higher recombinant species such as a mouse, or otherwise.
- the antibacterial enzymes may also be coated on the surface of the devices described herein by immersion of the device in a solution of the enzyme for a length of time sufficient to form a biofilm-formation inhibiting coating of the enzyme on the susceptible surface. Even the most minimal concentration of enzyme will confer some protection. Typically, a concentration of from about 10 pg/ml to about 100 mg/ml can be used. With device surfaces, the coatings may also be formed by covalent attachment of the enzyme thereto.
- the devices described herein can be coated with an antiseptic coating by any suitable technique such as immersion of the part into an antiseptic solution, by spray coating the part with the antiseptic solution, by blending the antiseptic solution or material into the polymeric material used to fabricate the device.
- a quantity of physiological, antimicrobial metal compound is added to the resin for direct molding of an article.
- Physiological, antimicrobial metals are meant to include the precious metals, such as silver, gold and platinum, and copper and zinc.
- Physiological, antimicrobial metal compounds used herein include oxides and salts of preferably silver and also gold, for example: silver acetate, silver benzoate, silver carbonate, silver citrate, silver chloride, silver iodide, silver nitrate, silver oxide, silver sulfa diazine, silver sulfate, gold chloride and gold oxide.
- Platinum compounds such as chloroplatinic acid or its salts (e.g., sodium and calcium chloroplatinate) may also be used.
- compounds of copper and zinc may be used, for example: oxides and salts of copper and zinc such as those indicated above for silver.
- Single physiological, antimicrobial metal compounds or combinations of physiological, antimicrobial metal compounds may be used.
- Preferred physiological, antimicrobial metal compounds used in this invention are silver acetate, silver oxide, silver sulfate, gold chloride and a combination of silver oxide and gold chloride. The particles of the silver compounds are sufficiently able to be extracted to form a zone of inhibition to prevent and kill bacteria growth.
- the devices herein are impregnated with triclosan and silver compounds or triclosan and chlorhexidine.
- a syringe having a tip cap with an antiseptic cap disposed thereon is generally indicated at 610.
- the syringe 612 includes a barrel 614 having a forward end 616.
- the forward end of the syringe 612 is configured with an access point connection 618 for attachment to an access point to deliver a fluid or medicament to a patient.
- the syringe access point connection 618 is covered with a tip cap 620.
- the tip cap 620 has a proximal end 621 that is attached to the access point connection of the syringe 612.
- the tip cap 620 also has a distal end 641 that carries an antiseptic cap 82.
- the antiseptic cap 82 could contain an absorbent material such as a sponge 86.
- the sponge 86 could be made from bonded fiber such as the bonded fiber material which is available from Filtrona Porous Technologies, based in Richmond, VA. The sponge 86 can store an antiseptic liquid.
- a cap assembly 680 is sealed by a cover or film 650 which is attached to the surface of the tip cap 620 such as to a flange 648.
- a pull tab 652 may be provided for facilitating removal of the film 650 to provide access to the antiseptic cap 82.
- the tip cap 620 has proximal and distal chambers 622 and 642 respectively, positioned within a cylindrical or tapered side wall 624.
- the side wall 624 is shown to be continuous but it could have discrete areas of different sizes to accommodate chambers of different sizes.
- the side wall 624 could include ribs or gripping surfaces to facilitate handling thereof.
- the proximal chamber 622 is configured for attachment to the access point connection 618 on the forward end 616 of the barrel 614 of the syringe 612 as is known. As shown, the proximal chamber 622 of the tip cap 620 receives and releasably engages the central male extension of the access point connection 618, as well as the annular surface that extends thereabout.
- the configuration of the proximal chamber 622 can be varied in accordance with what is known in the art.
- the proximal chamber 622 could have a base wall 626.
- the distal chamber 642 is sized and configured to receive an antiseptic cap 82.
- the distal chamber 642 could have a base wall 646.
- the antiseptic cap 82 could have one or more ribs 643 as shown in FIG. 64, and the inner wall of the distal chamber 642 could have corresponding ribs 645 to prevent relative rotational movement between the distal chamber 642 and the antiseptic cap 82.
- a syringe with an antiseptic cap 82 is provided with a fluid or medicament for delivery to a patient through an access point.
- the tip cap 620 is removed from the syringe 612 and the syringe 612 is connected to the access point and actuated to deliver the fluid or medicament.
- the syringe 612 is then disconnected from the access point, the tip cap 620 is accessed, and the pull tab 652 is used to remove the cover 650 to provide access to the antiseptic cap 82.
- gripping the tip cap 620 one places the antiseptic cap 82 on the access point and pushes and/or twists the antiseptic cap 82 onto the access point.
- the tip cap 620 can be removed such that the antiseptic cap 82 is withdrawn from the distal chamber 642 and remains attached to the access point where it disinfects and protects the access point until the next time the access point is accessed.
- FIG. 65 shows another aspect of a tip cap 720 wherein a distal chamber 742 is configured to receive a cap holder assembly 780 having an antiseptic cap.
- the tip cap 720 has a proximal end 721 and a distal end 741.
- the distal chamber 742 is configured in accordance with the configuration of the chamber of the plunger equipped antiseptic cap previously described and receives the cap holder assembly 780 therein.
- the antiseptic cap can be used as discussed previously, or the cap holder assembly 780 can be removed from the tip cap 720 and used directly.
- FIG. 66 shows another aspect of a tip cap 820 wherein a distal chamber 842 is configured to receive a cap holder assembly 880 having an antiseptic cap.
- the tip cap 820 has a proximal section 821 and a distal section 841.
- the proximal section 821 and the distal section 841 can be two discrete sections of varying shape and size.
- the proximal section 821 could have a cylindrical or tapered side wall, as shown.
- the discrete sections of varying shape or size can accommodate chambers of different sizes.
- the discrete sections, e.g., the proximal section 821 and the distal section 841 could include ribs 843 or gripping surfaces to facilitate handling thereof.
- the tip cap 820 is configured to change geometry from the proximal section 821 to the distal section 841.
- the proximal section 821 is shown to have a truncated conical shape and configured to attach to the access point connection 618 of a syringe 612, while the distal section 841 is designed and configured to receive the cap holder assembly 880.
- the cap holder assembly 880 may have ribs 845 that coact with ribs 843 on the distal chamber 842 to prevent rotation of the cap holder assembly 880 with respect to the tip cap 820.
- the antiseptic cap can be used as discussed previously, or the cap holder assembly 880 can be removed from the tip cap 820 and used directly.
- FIG. 67A is a cross-sectional view showing a syringe with an antiseptic cap assembly 980a disposed thereon generally indicated at 910.
- the syringe 912 includes a barrel 914 having a forward end 916.
- the forward end 916 of the syringe 912 is configured with an access point connection 918 and a cylindrical wall 919 for attachment to an access point to deliver a fluid or medicament to a patient.
- the syringe access point connection 918 Prior to use, the syringe access point connection 918 is covered with a cap assembly 980a that engages the cylindrical wall 919.
- the cap assembly 980a includes an antiseptic cap 982a and a flexible ring 984a.
- the flexible ring 984a could be formed by an extension of the outer surface 983 of the cap assembly 980 or, the flexible ring 984a could be in the form of a flexible cap having a top 985b and a circular ring 987b with a cap assembly 980b attached to the top 985b, as shown in FIG. 67B.
- the cap assembly 980 is attached to the cylindrical wall 919 of the syringe 612 by stretching the flexible ring 984 around the cylindrical wall 919 such that the flexible ring 984 forms around and engages the cylindrical wall 919.
- the flexible ring 984 is biased towards a normal diameter that is smaller than, or equal to, the diameter of the cylindrical wall 919, such that the cap assembly 980 is secured to the syringe 912.
- FIG. 68 is a side view showing a syringe with an antiseptic cap assembly attached to a tip cap disposed thereon generally indicated at 1010.
- the syringe 1012 includes a barrel 1014 having a forward end 1016.
- the forward end 1016 of the syringe 1012 is configured with an access point connection for attachment to an access point to deliver a fluid or medicament to a patient.
- the syringe access point connection Prior to use, the syringe access point connection is covered with a tip cap 1020.
- the tip cap 1020 has a proximal end 1021 that is attached to the access point connection of the syringe 1012.
- the tip cap 1020 also has a distal end 1041 comprising a snap-fit flange 1042.
- a cap holder assembly 1080 carries an antiseptic cap 1082 and includes a snap-fit chamber 1084 located at a bottom thereof.
- the snap-fit chamber 1084 is configured to mate with the snap-fit flange 1042.
- the antiseptic cap 1082 could be applied while the antiseptic cap holder assembly 1080 is attached to the tip cap 1020 or the antiseptic cap holder assembly 1080 can be removed from the tip cap 1020 and used separately.
- a tip cap and cap holder assembly combination are generally indicated at 1110.
- the tip cap 1120 has a proximal end 1121 that is attached to the access point connection of a syringe and a distal end 1141 comprising a distal end wall 1149 having a distal locking chamber 1142 disposed therein.
- a cap holder assembly 1180 has a proximal end 1181.
- the proximal end 1181 of the cap holder assembly 1180 includes a locking protrusion 1160 comprising a stem 1162 and a locking flange 1164, discussed in greater detail below.
- the tip cap 1120 includes a proximal chamber 1122 and the distal locking chamber 1142 positioned within a cylindrical or tapered side wall 1124.
- the side wall 1124 could include ribs or gripping surfaces to facilitate handling thereof.
- the proximal chamber 1122 is configured for attachment to an access point connection on a forward end of a barrel of a syringe as is known.
- the configuration of the proximal chamber 1122 can be varied in accordance with what is known in the art.
- the distal locking chamber 1142 comprises a circular chamber having an oblong or oval entrance 1154.
- the locking flange 1164 on the locking protrusion 1160 of the cap holder assembly 1180 has an oblong or oval shape configured to match the shape of the entrance 1154 of the distal locking chamber 1142.
- the stem 1162 preferably has a wall thickness that matches the distal end wall 1149 of the tip cap 1120. This configuration allows the locking flange 1164 to be inserted into the distal locking chamber 1142.
- the cap holder assembly 1180 can be rotated, such as by 90 degrees, such that the locking flange 1164 rotates in the circular distal locking chamber 1142, to retain the locking flange 1164 in the chamber 1142 such that the locking flange 1164 cannot be pulled therefrom because of the oblong or oval entrance 1154.
- the cap holder assembly 1180 is locked to the tip cap 1120 until it is rotated an additional 90 degrees.
- other locking flange 1164 and entrance or cut out 1154 geometries are contemplated, and they are not limited to solely oblong or oval geometries.
- the locking flange 1164 and the entrance or cut out 1154 may be matching asymmetrical designs, rectangular, triangular, or any other geometric arrangement.
- the antiseptic cap 1182 could be applied while the antiseptic cap holder assembly 1180 is attached to the tip cap 1120 or the antiseptic cap holder assembly 1180 can be removed from the tip cap 1120 and used separately.
- a syringe assembly having a plunger configured for removably receiving an antiseptic cap is shown generally at 1210.
- the syringe 1210 has a barrel 1214 and a plunger 1240.
- the plunger 1240 has a proximal end 1242 that includes a chamber 1260, sized to receive and removably hold a cap holder assembly 1220.
- the chamber 1260 is defined by a bottom wall 1261, and an annular sidewall 1262 that has a peripheral proximal end 1266 that defines an opening 1268 through which the cap holder assembly 1220 can be inserted into the chamber 1260.
- the cap holder assembly 1220 comprises a cap holder 1222, an antiseptic cap 1282, a sponge 1286 in some cases, an antiseptic material, and a cover or film 1250.
- a pull tab 1252 could be provided for facilitating removal of the film 1250 from the cap holder 1222 to provide access to the antiseptic cap 1282.
- the cap holder 1222 could have a distal end 1224 and one or more bulges 1228 on the outer surface 1226 to secure the cap holder assembly 1220 in the chamber 1260.
- the sidewall 1262 of the plunger 1240 includes one or more apertures 1270 defined by edges 1272.
- the one or more apertures 1270 provide access to the chamber 1260 and facilitate removal of the cap holder assembly 1220 from the plunger 1240 as will be described hereinafter.
- the cap holder assembly 1220 can be removed from the plunger 1240 and the process thereof is shown in FIGS. 75 and 76. As shown in FIG. 75, removal of the cap holder assembly 1220 from the plunger 1240 involves placing one's thumb or finger through the one or more apertures 1270 against a lower surface of the the cap holder assembly 1220. As shown in FIG. 76, one thereafter pushes against the cap holder assembly 1220 with a finger or thumb to urge the cap holder assembly 1220 out of the chamber 1260. Ultimately, the cap holder assembly 1220 is ejected from the chamber 1260. In this way, the antiseptic cap 1282 could be conveniently used at a different time than the syringe 1210.
- FIGS. 77-80 show another embodiment of a chamber 1360 of a plunger 1340 wherein an interior surface 1374 of the chamber 1360 of the plunger 1340 could have a plurality of circumferentially spaced ribs 1376 that contact the cap holder assembly 1320 to secure the cap holder assembly 1320 in the chamber 1360.
- the ribs 1376 could each contain a first groove 1378 shaped to accept the bulge 1328 of the cap holder 1322 to further secure the cap holder assembly 1320 within the chamber 1360.
- applying pressure to the cap holder assembly 1320 disengages the bulge 1328 from the groove 1378, as shown in FIG. 80. Further pressure against the cap holder assembly 1320 continues the removal process.
- the ribs 1376 could also be tapered to facilitate the controlled removal of the cap holder assembly 1320, and prevent the cap holder assembly 1320 from ejecting too rapidly.
- the ribs 1376 can provide a decreasing amount of resistance against the bulge 1328 of the cap holder 1322 as the cap holder assembly 1320 is urged out of the chamber 1360.
- FIGS. 81-83 show another embodiment of a chamber 1460 of a plunger 1440.
- the chamber 1460 includes a plurality of ribs 1476.
- the ribs 1476 of the chamber 1460 could each contain a first groove 1478 and a shallower second groove 1480 closer to the proximal end 1466 of the chamber 1460 and shaped to accept the bulge 1428 of the cap holder 1422 of the cap holder assembly 1420.
- the bulge 1428 disengages the first groove 1478, and then, after continued pressure, engages the second groove 1480, and then is removed entirely.
- the second groove 1480 facilitates the controlled ejectment of the cap holder assembly 1420 from the chamber 1460 because less force is required to disengage the cap holder assembly 1420 from the second groove 1480 than from the first groove 1478.
- FIG. 84 is a perspective view showing a plunger 1540 having four support walls 1530 extending at 90 degree angles with respect to each other from a common point.
- one or more support walls 1530 Towards the proximal end 1542 of the plunger 1540, one or more support walls 1530 has a recessed area 1532 proximal the one or more apertures 1570 to facilitate removal of the cap holder assembly by providing more clearance for a user to place his or her thumb beneath the cap holder assembly as previously shown in FIGS. 75 and 76.
- the outermost edge of the recessed area 1532 is closer to the common point than the outermost edge of the rest of the sidewall 1530.
- the recessed area 1523 could be defined by a flat edge 1532a, sloped edge 1532b, or both, as shown in FIG. 84.
- FIG. 85 shows a plunger 1640 having a first set of four support walls 1630 at 90 degrees with respect to each other positioned at a distal portion of the plunger, and a second set of four support walls 1634 at a proximal portion 1642, some of which are spaced apart at a greater angle with respect to each other to allow a wider aperture 1670 in the sidewall 1662 of the chamber 1660. At least two of the support walls flank the aperture of the chamber, which facilitates access to, and removal of, the cap holder assembly by providing more clearance for a user's finger or thumb or other removal tool, if any.
- FIGS. 86 and 87 Shown in FIGS. 86 and 87 is a syringe having a gripping flange 1715 with one or more storage receptacles.
- the gripping flange 1715 of the syringe 1710 includes one or more fully or partially bounded apertures 1717 capable of receiving and holding a cap holder assembly 1720 and/or a pre-cleaner 1721.
- the pre-cleaner 1721 could be used where an access site was not previously disinfected by an antiseptic cap of the present invention, if at all. In such a circumstance, the pre-cleaner 1721 would disinfect the access site, the access site would be used, and then the antiseptic cap would be applied.
- the cap holder assembly 1720 can be attached within the aperture by a friction fit and the flange about the cap opening can contact the syringe gripping flange 1715, or the cap holder assembly could be otherwise engaged within the aperture.
- flange connector panels for receiving a cap holder assembly can be attached to standard gripping flanges of syringes.
- a flange connector panel 1846 could have an aperture capable of receiving and holding a cap holder assembly.
- the aperture 1817 could have a portion along the outer edge of the flange connector panel 1846 that is unbounded, or the aperture could be completely bounded by the flange connector panel 1846 (not shown).
- the flange connector panel 1846 includes a slot 1856 in a sidewall 1854 providing access to a sleeve portion 1848.
- the sidewall 1854 and sleeve portion 1848 are configured to receive a portion of a gripping flange 1815 of a syringe and thereby attach the connector panel 1846 to the syringe.
- the gripping flange 1815 is curved
- sleeve portion 1848 is similarly curved. This attachment could be maintained by a friction fit, or other means.
- FIGS. 90 and 91 show a similar device having an aperture 1917, where the slot 1956 providing access to the sleeve portion 1948 to receive a portion of the gripping flange 1915 is on another sidewall of the connector panel 1946.
- a flange connector panel 2046 comprises an aperture 2019 completely bounded by the flange connector panel 2046, and capable of receiving and holding a cap holder assembly.
- the flange connector panel 2046 includes a slot 2056 providing access to a sleeve portion 2048 having sockets 2049.
- the sockets 2049 correspond in shape and location to engagement teeth 2023 on a gripping flange 2015 extending from the perimeter of the gripping flange 2015. In this way, when the flange connector panel 2046 is engaged with the gripping flange 2015, the engagement teeth 2023 are received by the sockets 2049 to retain the flange connector panel 2046 on the gripping flange 2015.
- the teeth 2023 of the gripping flange can have two different sides: a gradually angled side 2029a, farthest from the plunger 2040, and a sharply angled side 2029b.
- the sockets 2049 can have corresponding angles.
- the gradually angled sides 2029a of the teeth 2023 and sockets 2049 provide for easy engagement of the connector panel 2046 to the gripping flange 2015, which the sharply angled sides 2029b of the teeth 2023 and sockets 2049 prevent disengagement, thereby locking the connector panel 2046 to the gripping flange 2015.
- a gripping flange 2115 includes a lip 2125 along its outer perimeter.
- a flange connector panel 2146 that includes an aperture 2119, a first pair of fingers 2149a, and a second pair of fingers 2149b extending from the bottom of the connector 2146 and configured to connect to the lip 2125 of the gripping flange 2115.
- the distance between the first pair of fingers 2149a and second pair of fingers 2149b could correspond to the width of the lip 2125 of the gripping flange 2115, such that the first and second pair of fingers 2149a, 2149b bear against the lip 2125 of the gripping flange 2115.
- the first pair of fingers 2149a could contact the top surface of the gripping flange 2125.
- the second pair of fingers 2149b could be longer than the first pair of fingers 2149a and comprise flanges 2151 configured to extend down and contact the bottom surface of the of the gripping flange 2115.
- the four fingers 2149a, 2149b are in a rectangular formation. However, the fingers could be of varying numbers, sizes (e.g., length or width), and/or formations, such as two fingers, six fingers, or a trapezoidal formation.
- FIGS. 96 and 97 show a cap holder assembly 2220 connected to the proximal end 2242 of plunger 2240 by a frangible attachment 2236.
- the frangible attachment 2236 can be made of plastic, and a user can remove the cap holder assembly 2220 from the plunger 2240 by breaking the frangible attachment 2236, such as by bending or twisting. In this way, the cap holder assembly 2220 could be conveniently used at a different time than the syringe 2210.
- the cap holder 2222 could have an annular protrusion 2238 extending from its distal end 2224 and encircling the frangible attachment 2236 to protect a user from contact and potential injury from the frangible attachment 2236 after breaking the frangible attachment 2236.
- 98 is a perspective view of a plunger 2340 having a receptacle 2333 extending transverse to the plunger 2340.
- the plunger 2340 has four support walls 2330a, 2330b, 2330c, and 2330d extending at 90 degree angles with respect to each other from a common point.
- One support wall 2330b has a discontinuance defined by end walls 2335a and 2335b.
- the support wall 2330d on the opposite sides has an internal recess defined by distal end wall 2335c, lateral end wall 2335d, and proximal end wall (not shown).
- Transverse support walls 2330a and 2330c have an inner circular wall 2335e forming an aperture that extends through walls 2330a and 2330c between the discontinuance in wall 2330b and the recess in wall 2330d, creating a receptacle in the plunger.
- the receptacle is shaped to receive a cap holder assembly 2320.
- Arrow A illustrates the path of insertion of the cap holder assembly 2320 into the receptacle in the plunger.
- the receptacle is circular, but the receptacle could be a variety of shapes.
- the lateral end wall 2335d of the cutout provides structure and rigidity and prevents over insertion of the cap holder assembly 2320.
- the cap holder assembly 2320 can be retained in the plunger 2340 by a friction fit, or other means.
- FIGS. 99-101 Shown in FIGS. 99-101 is a plunger 2440 having a receptacle 2433 at a proximal end extending transverse to the plunger 2440.
- the plunger 2440 has four support walls 2430a, 2430b, 2430c, and 2430d extending at 90 degree angles with respect to each other from a common point.
- Support walls 2430a and 2430c define the receptacle 2433 and could be square or rectangular to accommodate a square or rectangular cap holder of the cap holder assembly 2420.
- Arrow B illustrates the path of insertion of the plunger cap holder assembly 2420.
- Support wall 2430b has a break providing clearance for engagement of the cap holder assembly 2420 with the receptacle 2433.
- the support walls 2430 could include a cutout defining sidewalls 2435a and a bottom wall 2435b.
- the sidewalls 2435a of the cutout provide clearance for engagement of the cap holder assembly 2420 with the receptacle 2433.
- the bottom wall 2435b of the cutout provides structure and rigidity to the plunger 2440 and prevents over insertion of the cap holder assembly 2420.
- the cap holder assembly 2420 can be secured in the receptacle by a friction fit, or other means.
- a proximal end 2542 of a plunger 2540 comprises a proximal end wall 2543 having a proximal locking chamber 2547 disposed therein.
- the proximal locking chamber 2547 comprises a recessed circular chamber having an oblong or oval entrance 2549.
- the sidewall 2545 could include ribs or gripping surfaces (not shown) to facilitate handling thereof.
- the distal end 2524 of the cap holder 2522 comprises a locking protrusion 2588 having a circular stem 2590 and an oblong or oval locking flange 2592 that matches the shape of the entrance 2549 of the distal locking chamber 2547.
- the stem 2590 preferably has a wall thickness that matches the proximal end wall 2543 of the plunger 2540. This configuration allows the locking flange 2592 to be aligned with the entrance and inserted into the proximal locking chamber 2547.
- the cap holder assembly 2520 can be rotated (e.g., 90 degrees), as illustrated by Arrow C, such that the locking flange 2592 rotates in the circular proximal locking chamber 2547, to retain the locking flange 2592 in the chamber 2547 such that the locking flange 2592 cannot be pulled therefrom because of the oblong or oval entrance 2549.
- a friction fit could be provided to prevent accidental rotation/disengagement.
- the cap holder assembly 2520 could lock to the plunger 2540 until it is rotated an additional 90 degrees with respect to the plunger.
- locking flanges 2592, entrances 2549, and cutout geometries are contemplated, and they are not limited to solely oblong or oval geometries. Instead, the locking flange 2592 and the entrance 2549 or cutout may be matching asymmetrical designs, rectangular, triangular, or any other geometric arrangement.
- the antiseptic cap 2582 could be applied while the cap holder assembly 2520 is attached to the plunger 2540 or the cap holder assembly 2520 can be removed from the plunger 2540 and used separately.
- a sidewall 2662 of a chamber 2660 of a plunger 2640 comprises a locking lever 2664 having a proximal end 2668 and a distal end 2672, and is connected to the sidewall 2662 by a living hinge 2666, which acts as a fulcrum.
- the proximal end 2668 comprises a locking protrusion 2670 that engages a groove in the cap holder 2622 of the cap holder assembly 2620, thus locking it when the cap holder 2622 is secured within the chamber 2660 of the plunger 2640.
- the proximal end 2668 rotates about the living hinge 2666, illustrated by lines D, causing the locking protrusion 2670 to disengage from the groove in the cap holder 2622, thereby allowing removal of the cap holder assembly 2620 from the chamber 2660.
- the distal end 2772 of the locking lever 2764 could have a toe 2773 to facilitate removal of the cap holder assembly 2720 from the chamber 2760 of the plunger 2740.
- a first adhesive material 2894a is fixed to the distal end 2824 of a cap holder assembly 2820 and a second adhesive material 2894b is fixed to the proximal end 2842 of the plunger 2840 of the syringe.
- the two adhesive materials 2894a, 2894b are removably attachable to one another.
- the adhesive materials 2894a, 2894b could be any suitable adhesive or could be another type of material that can form a connection, such as hook and loop fasteners where material 2894a could be comprised of hooks, and material 2894b could be comprised of loops.
- the cap holder assembly 2820 could be repeatedly attached to the plunger 2840. Further, when the cap assembly 2820 is attached to the plunger 2840, the cap may be removed from the cap assembly 2820, without first having to remove the cap holder assembly 2820 from the plunger 2840.
- FIGS. 112 and 113 Another embodiment is shown in FIGS. 112 and 113, where a proximal end of the plunger comprises an axially compressible material 2998, such as foam or accordion folded plastic, defining a cavity.
- a cap holder assembly 2920 could be inserted into the cavity, such as by the path illustrated by Arrow G, and secured therein by the frictional radial force of the compressible material 2998 against the outer surface 2926 of the cap holder 2922.
- FIG. 113 when the compressible material 2998 is compressed, as illustrated by Arrows H, the cap holder assembly 2920 is easily gripped and removed.
- a plunger 3040 could have an annular flange 3067 at a peripheral proximal end 3066 of a chamber 3060 and a cap holder 3022 could have an annular flange 3027.
- the two flanges 3027, 3067 are spaced apart by a distance. The spaced distance allows a user to grip the flange 3027 of the cap holder 3022, and thus easily remove the cap holder assembly 3020 from the chamber 3060.
- 115-118 show another embodiment of the present invention comprising a radially compressible locking ring 3174 attached to a peripheral proximal end 3166 of a plunger 3140.
- the locking ring comprises press tabs 3178 and diametrically opposed locking tabs 3176. As shown in FIG. 116, the distance between the locking tabs 3176 is less than the diameter of the cap holder 3122, thus securing the cap holder assembly 3120 in the chamber 3160 of the plunger 3140.
- FIG. 118 shows another embodiment of the locking ring 3274 comprising locking tabs 3276 where the locking ring 3274 is generally circular in shape, and where a force applied, illustrated by lines K, results in the tabs 3276 separating, illustrated by lines L.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Packages (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES12845250T ES2907323T3 (en) | 2011-11-03 | 2012-10-26 | Syringe equipped with antiseptic stopper |
AU2012332901A AU2012332901B2 (en) | 2011-11-03 | 2012-10-26 | Antiseptic cap equipped syringe |
NZ624449A NZ624449B2 (en) | 2011-11-03 | 2012-10-26 | Antiseptic cap equipped syringe |
BR112014010805-6A BR112014010805B1 (en) | 2011-11-03 | 2012-10-26 | SYRINGE EQUIPPED WITH ANTISEPTIC COVER |
CN201280065923.4A CN104023768B (en) | 2011-11-03 | 2012-10-26 | It is equipped with the syringe of antibacterial cap |
EP12845250.5A EP2773398B1 (en) | 2011-11-03 | 2012-10-26 | Antiseptic cap equipped syringe |
CA2854296A CA2854296C (en) | 2011-11-03 | 2012-10-26 | Antiseptic cap equipped syringe |
JP2014540000A JP6087364B2 (en) | 2011-11-03 | 2012-10-26 | Syringe with syringe |
MX2014005371A MX345307B (en) | 2011-11-03 | 2012-10-26 | Antiseptic cap equipped syringe. |
HK15102429.0A HK1201770A1 (en) | 2011-11-03 | 2015-03-10 | Antiseptic cap equipped syringe |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/288,529 | 2011-11-03 | ||
US13/288,529 US9700710B2 (en) | 2006-06-22 | 2011-11-03 | Antiseptic cap equipped syringe |
US13/547,650 | 2012-07-12 | ||
US13/547,650 US9259535B2 (en) | 2006-06-22 | 2012-07-12 | Antiseptic cap equipped syringe |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013066742A1 true WO2013066742A1 (en) | 2013-05-10 |
Family
ID=48192646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/062078 WO2013066742A1 (en) | 2011-11-03 | 2012-10-26 | Antiseptic cap equipped syringe |
Country Status (12)
Country | Link |
---|---|
US (4) | US9259535B2 (en) |
EP (1) | EP2773398B1 (en) |
JP (1) | JP6087364B2 (en) |
CN (1) | CN104023768B (en) |
AU (1) | AU2012332901B2 (en) |
BR (1) | BR112014010805B1 (en) |
CA (1) | CA2854296C (en) |
CO (1) | CO7030941A2 (en) |
ES (1) | ES2907323T3 (en) |
HK (1) | HK1201770A1 (en) |
MX (1) | MX345307B (en) |
WO (1) | WO2013066742A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9186707B2 (en) | 2007-04-02 | 2015-11-17 | C. R. Bard, Inc. | Insert for a microbial scrubbing device |
US9192449B2 (en) | 2007-04-02 | 2015-11-24 | C. R. Bard, Inc. | Medical component scrubbing device with detachable cap |
WO2016174471A1 (en) * | 2015-04-30 | 2016-11-03 | Steven Gill Anaesthetic Services Ltd | Injectables |
USD834187S1 (en) | 2016-01-18 | 2018-11-20 | Becton, Dickinson And Company | Disinfecting cap |
US10245342B2 (en) | 2012-06-22 | 2019-04-02 | Health Line International Corp. | Antimicrobial devices for use with medical devices and related assemblies and methods |
US11571505B2 (en) | 2015-11-27 | 2023-02-07 | Sanofi-Aventis Deutschland Gmbh | Drug delivery device with a cap |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8740864B2 (en) | 2005-11-17 | 2014-06-03 | Becton, Dickinson And Company | Patient fluid line access valve antimicrobial cap/cleaner |
US9259535B2 (en) | 2006-06-22 | 2016-02-16 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
US9700710B2 (en) | 2006-06-22 | 2017-07-11 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
US8167847B2 (en) | 2006-06-22 | 2012-05-01 | Excelsior Medical Corporation | Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly |
US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
WO2012162259A2 (en) | 2011-05-20 | 2012-11-29 | Excelsior Medical Corporation | Caps for cannula access devices |
US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
US9867975B2 (en) | 2011-05-23 | 2018-01-16 | Excelsior Medical Corporation | Antiseptic line cap |
WO2013009998A2 (en) | 2011-07-12 | 2013-01-17 | Pursuit Vascular, Inc. | Device for delivery of antimicrobial agent into trans-dermal catheter |
US8784388B2 (en) | 2011-09-30 | 2014-07-22 | Becton, Dickinson And Company | Syringe with disinfecting tip feature |
US9399125B2 (en) * | 2013-02-13 | 2016-07-26 | Becton, Dickinson And Company | Needleless connector and access port disinfection cleaner and antimicrobial protection cap |
US20170042636A1 (en) * | 2014-02-14 | 2017-02-16 | The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust | Disinfecting device |
US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
CA2945406C (en) * | 2014-05-02 | 2022-10-18 | Excelsior Medical Corporation | Strip package for antiseptic cap |
US9907912B2 (en) | 2014-09-26 | 2018-03-06 | John B. RANSOME | Gelatin bowel prep with syringe for colonoscopy |
US9527660B2 (en) * | 2014-12-31 | 2016-12-27 | Hyprotek, Inc. | Individually sealed antiseptic applicators |
WO2016123621A1 (en) * | 2015-01-30 | 2016-08-04 | Smiths Medical Asd, Inc. | Needle assembly with site preparation provisions |
JP7008507B2 (en) * | 2015-03-27 | 2022-01-25 | ハイプロテック、 インク. | Injection system including storage compartment |
WO2016172182A1 (en) * | 2015-04-24 | 2016-10-27 | Becton, Dickinson And Company | Button safety cap for catheter insertion device |
JP6822978B2 (en) | 2015-05-08 | 2021-01-27 | アイシーユー・メディカル・インコーポレーテッド | Medical connector configured to accept the emitter of a therapeutic agent |
US10828484B2 (en) | 2015-08-21 | 2020-11-10 | Medline Industries, Inc. | Disinfecting cap |
CN118079171A (en) * | 2015-09-04 | 2024-05-28 | 费雪派克医疗保健有限公司 | Catheter connector |
JP6745600B2 (en) * | 2016-01-29 | 2020-08-26 | 三菱鉛筆株式会社 | Disinfection cap for needleless connectors |
ITUB20160977A1 (en) * | 2016-02-23 | 2017-08-23 | Brev Angela Srl | Opening and dispensing system for pre-filled containers, relative pre-filled containers and procedures for their realization |
USD809656S1 (en) | 2016-06-10 | 2018-02-06 | Fisher & Paykel Healthcare Limited | Connector for a breathing circuit |
EP3266495A1 (en) * | 2016-07-07 | 2018-01-10 | Berlin Heart GmbH | Device for a lead-through for a line through the skin of a patient |
US10500368B2 (en) * | 2016-07-21 | 2019-12-10 | Germain Jean-Charles | Dental syringe |
FI3525865T3 (en) | 2016-10-14 | 2023-01-13 | Sanitizing caps for medical connectors | |
WO2018204206A2 (en) | 2017-05-01 | 2018-11-08 | Icu Medical, Inc. | Medical fluid connectors and methods for providing additives in medical fluid lines |
CN107126600B (en) * | 2017-05-23 | 2023-01-03 | 北京大学深圳医院 | Isolation protector and injection device with same |
EP3634562A1 (en) * | 2017-06-09 | 2020-04-15 | B. Braun Melsungen AG | Adhesive encased protective caps for needle devices and related methods |
CN107198407B (en) * | 2017-07-21 | 2019-03-15 | 京东方科技集团股份有限公司 | Anti-watering cup and its control method |
JP7495351B2 (en) * | 2018-03-16 | 2024-06-04 | アイシーユー・メディカル・インコーポレーテッド | Disinfection Cap for Medical Connectors |
CN115607822A (en) * | 2018-04-10 | 2023-01-17 | 贝克顿·迪金森公司 | Universal disposable lid for male and female connectors |
JP7315579B2 (en) * | 2018-04-10 | 2023-07-26 | ベクトン・ディキンソン・アンド・カンパニー | Universal single-use caps for male and female connectors |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
US11857320B2 (en) | 2018-06-08 | 2024-01-02 | Smiths Medical Asd, Inc. | Blood sequestration device and method |
US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
AU2019384564B2 (en) | 2018-11-21 | 2023-11-23 | Icu Medical, Inc. | Antimicrobial device comprising a cap with ring and insert |
EP3883486B1 (en) | 2018-11-22 | 2023-10-25 | AFreeze GmbH | Ablation device with adjustable ablation applicator size and ablation system |
US10946224B2 (en) | 2019-07-12 | 2021-03-16 | Frederick Thomas Strobl | Multi-stage nasal filter and method of tuning the filter to a predetermined most penetrating particle size |
US11786663B2 (en) | 2019-07-12 | 2023-10-17 | Becton, Dickinson And Company | Integrated disinfection device |
US20220313976A1 (en) * | 2019-07-24 | 2022-10-06 | 3M Innovative Properties Company | Cleaning cap for medical implement |
EP4010060A1 (en) * | 2019-08-08 | 2022-06-15 | Becton, Dickinson and Company | Universal cap with pressure seal |
USD948027S1 (en) | 2019-09-10 | 2022-04-05 | Fisher & Paykel Healthcare Limited | Connector for a breathing conduit |
US11285345B2 (en) | 2020-03-02 | 2022-03-29 | Frederick Thomas Strobl | Multi-stage nasal filter |
CN111570433A (en) * | 2020-05-24 | 2020-08-25 | 江山市发发科技有限公司 | Membrane isolation disinfection storage flusher |
CA3204371A1 (en) | 2020-12-07 | 2022-06-16 | Icu Medical, Inc. | Peritoneal dialysis caps, systems and methods |
US11147959B1 (en) | 2021-03-31 | 2021-10-19 | Jason Lakis | Syringe apparatus for disinfection of central line port needleless connector and method of disinfecting a central line port needleless connector |
USD995758S1 (en) | 2021-06-11 | 2023-08-15 | Fisher & Paykel Healthcare Limited | Tube assembly and connector |
DE102021131267A1 (en) * | 2021-11-29 | 2023-06-01 | Fresenius Medical Care Deutschland Gmbh | Sealing cap for liquid connections of a dialyzer |
WO2024039526A1 (en) * | 2022-08-17 | 2024-02-22 | Becton, Dickinson And Company | Pre-filled lock syringe with integrated cap |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246011A (en) * | 1992-01-30 | 1993-09-21 | Caillouette James C | Fine needle aspiration syringe |
RU2246321C1 (en) * | 2003-08-04 | 2005-02-20 | Мамаев Геннадий Викторович | Container-type syringe |
WO2009002474A1 (en) | 2007-06-22 | 2008-12-31 | Excelsior Medical | Antiseptic cap with thread cover |
US20090062766A1 (en) | 2007-01-16 | 2009-03-05 | Howlett Michael W | Sterility-protecting caps with fluid reservoir for separated connectors |
US20100047123A1 (en) | 2007-01-16 | 2010-02-25 | The University Of Utah Research Foundation | Sterilization caps and systems and associated methods |
Family Cites Families (493)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US559697A (en) | 1896-05-05 | Two-compartment bottle | ||
US877946A (en) | 1907-02-04 | 1908-02-04 | Henry Solomon Wellcome | Apparatus for containing and injecting serums and other substances. |
US975939A (en) | 1910-04-12 | 1910-11-15 | Hardsocg Mfg Co | Compartment-canteen. |
GB123221A (en) | 1918-04-09 | 1919-02-20 | Frank Keil | Improvements relating to the Nipples of Soothing-teats, Feeding-bottles and the like. |
US1445642A (en) | 1921-09-10 | 1923-02-20 | O'neill Henry | Flask |
US1793068A (en) | 1930-01-06 | 1931-02-17 | Fairleigh S Dickinson | Hypodermic syringe and needle therefor |
US2098340A (en) | 1936-12-07 | 1937-11-09 | Joseph P Henahan | Oral airway dam |
US2436297A (en) | 1944-07-25 | 1948-02-17 | Guarnaschelli Vincent | Bottle cap |
US2457052A (en) | 1946-01-30 | 1948-12-21 | Tecalemit Ltd | Coupling for use in fluid supply systems |
US2771644A (en) | 1950-08-07 | 1956-11-27 | Dole Eng Co James | Apparatus for sterilizing container covers |
US3270743A (en) | 1963-05-29 | 1966-09-06 | Leeming Miles Pharmaccuticals | Hypodermic injection syringe |
US3262448A (en) | 1963-11-06 | 1966-07-26 | Sorenson Res Corp | Intravenous catheter placement unit |
US3301392A (en) | 1965-11-24 | 1967-01-31 | Ethicon Inc | Nested package |
US3411665A (en) | 1966-05-06 | 1968-11-19 | Ultra Custom Pak Inc | Disposable container, container package and dispensing structure |
US3604582A (en) | 1968-07-29 | 1971-09-14 | Pierre Boudin | Containers for protecting children against dangerous products |
US3595241A (en) | 1969-02-19 | 1971-07-27 | David S Sheridan | Insured internal flow medicosurgical tubes |
US3538950A (en) | 1969-04-16 | 1970-11-10 | Locking Devices Inc | Quick connect lugged coupling |
DE2320373B2 (en) | 1973-04-21 | 1978-04-06 | Merck Patent Gmbh, 6100 Darmstadt | Antibiotic agent and its use as a plastic surgical material |
US3977517A (en) | 1974-07-22 | 1976-08-31 | Bausch & Lomb Incorporated | Contact lens carrying case |
US3987930A (en) | 1974-09-26 | 1976-10-26 | Ethicon, Inc. | Dual-ended tubing cap |
US3977401A (en) | 1975-03-25 | 1976-08-31 | William Floyd Pike | Injection apparatus |
US4113751A (en) | 1975-10-10 | 1978-09-12 | Schering Aktiengesellschaft | Stabilizer for estrogens |
US4041934A (en) | 1976-02-02 | 1977-08-16 | Abbott Laboratories | Arterial blood sampling unit |
US4046889A (en) | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
US4052511A (en) | 1976-02-13 | 1977-10-04 | E. R. Squibb & Sons, Inc. | Carboxyacylproline derivatives |
US4053651A (en) | 1976-05-10 | 1977-10-11 | E. R. Squibb & Sons, Inc. | Compounds and method for alleviating angiotensin related hypertension |
US4078686A (en) | 1977-01-05 | 1978-03-14 | Karesh Myrna M | Two-way jar |
US4113715A (en) | 1977-01-17 | 1978-09-12 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
US4095810A (en) | 1977-01-17 | 1978-06-20 | Baxter Travenol Laboratories, Inc. | Gill-type tip protector for sealing open tubes and the like |
US4133441A (en) | 1978-03-23 | 1979-01-09 | Baxter Travenol Laboratories, Inc. | Injection site |
US4192443A (en) | 1978-07-10 | 1980-03-11 | Champion International Corporation | Divided paperboard tray |
US4461896A (en) | 1979-02-07 | 1984-07-24 | Norwich Eaton Pharmaceuticals, Inc. | 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids |
US4334551A (en) | 1979-04-30 | 1982-06-15 | Becton Dickinson & Company | Connector |
US4243035A (en) | 1979-06-18 | 1981-01-06 | Barrett Howard G | Syringe with integral swab |
JPS5748766Y2 (en) | 1979-09-17 | 1982-10-26 | ||
PT70158A1 (en) | 1980-03-03 | 1982-03-01 | Univ Miami | Process for preparing anti-hypertensive agents |
US4692458A (en) | 1980-03-05 | 1987-09-08 | University Of Miami | Anti-hypertensive agents |
US4294370A (en) | 1980-03-24 | 1981-10-13 | Toeppen Thurston H | Threaded closure and container |
US4350704A (en) | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
US4810241A (en) | 1980-06-09 | 1989-03-07 | Rogers Phillip P | Ambulatory dialysis system and connector |
US4337327A (en) | 1980-07-07 | 1982-06-29 | S.K.Y. Polymers, Inc. | Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same |
US4370451A (en) | 1980-07-07 | 1983-01-25 | S.K.Y. Polymers | Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same |
US4379874A (en) | 1980-07-07 | 1983-04-12 | Stoy Vladimir A | Polymer composition comprising polyacrylonitrile polymer and multi-block copolymer |
US4420589A (en) | 1980-07-07 | 1983-12-13 | Stoy Vladimir A | Polymer composition including polyacrylonitrile polymers and process for preparing same |
US4317446A (en) * | 1980-09-04 | 1982-03-02 | Schering Corporation | Prefilled disposable syringe |
US4331783A (en) | 1980-09-17 | 1982-05-25 | S.K.Y. Polymers | Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same |
US4369294A (en) | 1980-09-17 | 1983-01-18 | S.K.Y. Polmers | Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same |
FR2493149A1 (en) | 1980-11-05 | 1982-05-07 | Materiels Annexes Dialyse | DEVICE FOR PROTECTING A CONNECTION TIP BY A DISINFECTANT |
US4335756A (en) | 1981-01-21 | 1982-06-22 | Texas Medical Products, Inc. | Sterilized medical tubing cover |
US4728075A (en) | 1981-01-28 | 1988-03-01 | Paradis Joseph R | Control of fluid flow |
JPS6018374Y2 (en) | 1981-02-12 | 1985-06-04 | 三陽紙器株式会社 | double cup container |
US4507111A (en) | 1981-03-09 | 1985-03-26 | Whitman Medical Corporation | Surgical scrub |
US4427126A (en) | 1981-06-08 | 1984-01-24 | Ethyl Products Company | Vented closure |
US4402691A (en) | 1981-07-24 | 1983-09-06 | The Clinipad Corporation | Aseptic connection barrier system and method |
US4384589A (en) | 1981-07-27 | 1983-05-24 | American Cyanamid Company | Novel liquid delivery system for toiletries |
US4432766A (en) | 1981-07-29 | 1984-02-21 | Baxter Travenol Laboratories, Inc. | Conduit connectors having antiseptic application means |
US4417890A (en) | 1981-08-17 | 1983-11-29 | Baxter Travenol Laboratories, Inc. | Antibacterial closure |
US4390016A (en) | 1981-10-23 | 1983-06-28 | Temp-Trak Inc. | Prefillable hypodermic syringe and method of assembling the syringe |
IT1195287B (en) | 1981-11-05 | 1988-10-12 | Ausonia Farma Srl | THIAZOLIC DERIVATIVE, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS |
US4480940A (en) | 1982-04-14 | 1984-11-06 | American Cyanamid Company | Flexible diaphragm for dispensing product |
US4461368A (en) | 1982-04-15 | 1984-07-24 | Plourde R Gilles | Diaphragm cover for a stethoscope |
US4457749A (en) | 1982-04-19 | 1984-07-03 | Baxter Travenol Laboratories, Inc. | Shield for connectors |
US4681886A (en) | 1982-04-30 | 1987-07-21 | E. R. Squibb & Sons, Inc. | Substituted 4-phenoxy or 4-phenylthio prolines |
US4439184A (en) | 1982-05-03 | 1984-03-27 | Concord Laboratories, Inc. | Two-dose syringe |
US4446967A (en) | 1982-05-07 | 1984-05-08 | Halkyard Douglas R | Germicide sleeve for dental and medical instruments |
US4440207A (en) | 1982-05-14 | 1984-04-03 | Baxter Travenol Laboratories, Inc. | Antibacterial protective cap for connectors |
US4444310A (en) | 1982-07-26 | 1984-04-24 | Becton, Dickinson And Company | Segmented multi-product package assembly |
US4769013A (en) | 1982-09-13 | 1988-09-06 | Hydromer, Inc. | Bio-effecting medical material and device |
US4671306A (en) | 1982-10-25 | 1987-06-09 | Donald Spector | Nail-polish-removing thimble |
US5688254A (en) | 1983-01-24 | 1997-11-18 | Icu Medical, Inc. | Medical connector |
DK130584A (en) | 1983-04-08 | 1984-10-09 | Ciba Geigy Ag | N- (2-NITROPHENYL) -4-AMINO-PYRIMIDINE DERIVATIVES AND THEIR PREPARATION AND USE AS MICROBICIDES |
US4778447A (en) | 1983-05-20 | 1988-10-18 | Travenol European Research & Development Center | Connectors |
US4585758A (en) | 1983-05-20 | 1986-04-29 | Usv Pharmaceutical Corp. | Angiotensin-converting enzyme inhibitors |
US4631188A (en) | 1983-08-31 | 1986-12-23 | S.K.Y. Polymers, Ltd. (Kingston Technologies) | Injectable physiologically-acceptable polymeric composition |
US4568675A (en) | 1983-12-19 | 1986-02-04 | E. R. Squibb & Sons, Inc. | Phenazine ACE inhibitor produced from streptomyces species |
EP0179089A1 (en) | 1984-04-30 | 1986-04-30 | Baxter Travenol Laboratories, Inc. | Connection site protector |
US4626545A (en) | 1984-08-27 | 1986-12-02 | Merck & Co., Inc. | Amino acid derivatives as enzyme inhibitors |
GB8422165D0 (en) | 1984-09-01 | 1984-10-03 | Wellcome Found | Compounds |
US4559043A (en) | 1984-10-29 | 1985-12-17 | Drs Infusion Systems, Inc. | Assembly with septum fitting for connecting adaptor and fluid tube |
EP0183398B1 (en) | 1984-11-30 | 1989-04-12 | FISONS plc | Angiotensin converting enzyme inhibitors and their production and use as pharmaceuticals |
SE453362B (en) | 1984-12-27 | 1988-02-01 | Viggo Ab | SET TO REDUCE THE RISK OF PARTICLE CONTAMINATION INJECTION AND INJECTION INSTRUMENTS |
US5154920A (en) | 1985-03-13 | 1992-10-13 | Ecolab Inc. | Disinfectant polymeric coatings for hard surfaces |
FR2581039B1 (en) | 1985-04-24 | 1987-06-26 | Bendix France | TANK CAP |
DE3515665C1 (en) | 1985-05-02 | 1986-05-15 | Gerhard 6393 Wehrheim Pfetzing | Closure plug |
DE3523520A1 (en) | 1985-07-01 | 1987-01-08 | Stoeckert Instr Gmbh | VESSEL CATHETER |
US4624664A (en) | 1985-07-22 | 1986-11-25 | Travenol European Research And Development Centre (Teradec) | Antibacterial closure system |
JPS6279062A (en) | 1985-09-30 | 1987-04-11 | 株式会社 日本メデイカル・サプライ | Method and apparatus for asceptic connection of connector |
EP0240561B1 (en) | 1985-10-29 | 1990-03-21 | National Research Development Corporation | Feeding appliance |
US5552115A (en) | 1986-02-06 | 1996-09-03 | Steris Corporation | Microbial decontamination system with components porous to anti-microbial fluids |
EP0237239A3 (en) | 1986-02-28 | 1988-08-17 | The Wellcome Foundation Limited | New compounds |
US4704760A (en) | 1986-05-16 | 1987-11-10 | Grieshaber Herman R | Surgical blade cleaning device |
US4834271A (en) | 1986-08-04 | 1989-05-30 | Litwin Walter J | One-piece dispensing closure |
US4703762A (en) | 1986-08-04 | 1987-11-03 | Rathbone R Rodion | Blood sampling device for obtaining dual samples of venous blood |
DE3629060A1 (en) | 1986-08-27 | 1988-03-03 | Bayer Ag | COMBINATION OF POSITIVELY INOTROP ACTING DIHYDROPYRIDINES WITH ACE INHIBITORS, AND THEIR USE IN MEDICINAL PRODUCTS |
US4747502A (en) | 1986-10-07 | 1988-05-31 | Ethyl Molded Products Company | Vented beverage closure |
US4728321A (en) | 1987-04-16 | 1988-03-01 | Ming-Chiu Wu | Syringe cap with adhesive holding plug |
US4894056A (en) | 1987-06-01 | 1990-01-16 | Bommarito Alexander A | Method and apparatus for clearing occluded lumens of enteral feeding tubes |
US4752983A (en) | 1987-07-09 | 1988-06-28 | Grieshaber Herman R | Surgical instrument cleaning device |
US5580530A (en) | 1987-07-30 | 1996-12-03 | Johnson & Johnson Medical, Inc. | Device for vapor sterilization of articles having lumens |
DE8817024U1 (en) | 1987-09-25 | 1991-12-12 | Industrie Borla S.p.A., Moncalieri, Turin/Torino | Gas-tight closure device for the connecting ends of tubes for biomedical fluid transport devices, in particular haemodialytic chains, which are sterilized by means of sterilizing gas |
US4799926A (en) | 1987-10-13 | 1989-01-24 | Habley Medical Technology Corporation | Syringe, having self-contained, sterile, medication applying swab |
US5019096A (en) | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
US4811847A (en) | 1988-03-14 | 1989-03-14 | Reif Thomas H | Urinary catheter package |
US4957637A (en) | 1988-05-23 | 1990-09-18 | Sherwood Medical Company | Serum separator system for centrifuge with piercable membrane |
DE8906628U1 (en) | 1988-06-01 | 1989-07-27 | Sterimed Gesellschaft für medizinischen Bedarf mbH, 6600 Saarbrücken | Luer-Lock nut for catheter hubs |
US5002964A (en) | 1988-06-15 | 1991-03-26 | Brigham & Women's Hospital | S-nitrosocaptopril compounds and the use thereof |
US5025001A (en) | 1988-06-15 | 1991-06-18 | Brigham And Women's Hospital | S-nitroso derivatives of ACE inhibitors and the use thereof |
FR2637254A1 (en) | 1988-10-03 | 1990-04-06 | Schiemann Dr Wolfram | PLASTIC BOTTLE DEVICE |
US5207706A (en) | 1988-10-05 | 1993-05-04 | Menaker M D Gerald | Method and means for gold-coating implantable intravascular devices |
CA1324045C (en) | 1989-02-24 | 1993-11-09 | Joseph E. Dadson | Connector cap and cover therefor |
US4927019A (en) | 1989-06-12 | 1990-05-22 | Habley Medical Technology Corporation | Combination needle sheath and sterility package |
US5015238A (en) | 1989-06-21 | 1991-05-14 | Becton, Dickinson And Company | Expandable obturator and catheter assembly including same |
US5212204A (en) | 1989-10-18 | 1993-05-18 | The United States Of America As Represented By The Department Of Health And Human Services | Antihypertensive compositions and use thereof |
US5674192A (en) | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5031622A (en) | 1990-03-28 | 1991-07-16 | Lahaye Laboratories, Inc. | Disposable anticontamination tonometer tip cover or cap |
US4989733A (en) | 1990-05-21 | 1991-02-05 | Marc Patry | Ready-to-use medical trays |
US5071413A (en) | 1990-06-13 | 1991-12-10 | Utterberg David S | Universal connector |
US5184742A (en) | 1990-06-18 | 1993-02-09 | Boc Health Care, Inc. | Deadender cap for luer fitting |
JPH0499950A (en) | 1990-08-17 | 1992-03-31 | Fujitsu Ltd | Soldering inspection apparatus |
US5155137A (en) | 1990-09-20 | 1992-10-13 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Complexes of nitric oxide with polyamines |
US5065783A (en) | 1990-09-20 | 1991-11-19 | George Braddock Ogle, II | Valve with self-sealing internal cannula |
EP0560928B1 (en) | 1990-12-05 | 1997-09-24 | The General Hospital Corporation | Use of no for the treatment or prevention of bronchoconstriction |
US5536241A (en) | 1990-12-05 | 1996-07-16 | The General Hospital Corporation | Methods and devices for relaxing smooth muscle contractions |
US5143104A (en) | 1990-12-07 | 1992-09-01 | Allergan, Inc. | Vented apparatus for storing and cleaning an element |
US5190534A (en) | 1990-12-07 | 1993-03-02 | Delmed, Inc. | Prefilled sterilant fluid releasable coupling connector apparatus for catheter applications |
US5324261A (en) | 1991-01-04 | 1994-06-28 | Medtronic, Inc. | Drug delivery balloon catheter with line of weakness |
US5195957A (en) | 1991-02-01 | 1993-03-23 | Tollini Dennis R | Sterilant cartridge-cap and associated connection |
US5380758A (en) | 1991-03-29 | 1995-01-10 | Brigham And Women's Hospital | S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
US5242421A (en) | 1991-08-06 | 1993-09-07 | Chan Mark S H | Needle cap |
WO1993007114A1 (en) | 1991-09-24 | 1993-04-15 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs |
USD342134S (en) | 1991-10-28 | 1993-12-07 | Coast Medical, Inc. | End cap for medical tubing |
US5205821A (en) | 1991-11-01 | 1993-04-27 | Abbott Laboratories | Terminal self-releasing fluid reservoir |
US5242425A (en) | 1991-11-14 | 1993-09-07 | Gish Biomedical, Inc. | Antiseptic catheter coupling septum |
ES2106318T3 (en) | 1991-12-06 | 1997-11-01 | North Shore Univ Hospital | METHOD TO REDUCE INFECTIONS RELATED TO MEDICAL DEVICES. |
US5624414A (en) | 1992-02-18 | 1997-04-29 | St. Francis Research Institute | Needleless straight infusion port |
US5599352A (en) | 1992-03-19 | 1997-02-04 | Medtronic, Inc. | Method of making a drug eluting stent |
US5814666A (en) | 1992-04-13 | 1998-09-29 | The United States As Represented By The Department Of Health And Human Services | Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
AU3969793A (en) | 1992-04-13 | 1993-11-18 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Use of nitric oxide/nucleophile complexes for the treatment of cancer |
US5272074A (en) | 1992-04-23 | 1993-12-21 | Mcmaster University | Fibrin coated polymer surfaces |
SE9201718D0 (en) | 1992-06-03 | 1992-06-03 | Astra Ab | NASAL SPRAY DEVICE |
US5337730A (en) | 1992-06-18 | 1994-08-16 | The United States Of America As Represented By The Secretary Of The Air Force | Endoscope cleansing catheter and method of use |
US5278192A (en) | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
US5405919A (en) | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US5525357A (en) | 1992-08-24 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US6200558B1 (en) | 1993-09-14 | 2001-03-13 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US5496288A (en) | 1992-09-23 | 1996-03-05 | Becton, Dickinson And Company | Protective cap for hypodermic syringe |
US5240675A (en) | 1992-09-24 | 1993-08-31 | Wilk Peter J | Method for cleaning endoscope |
US5330899A (en) | 1992-10-13 | 1994-07-19 | Bio-Plas, Inc. | Calibrated inoculation assembly and method of preserving sterility |
US5471706A (en) | 1992-12-14 | 1995-12-05 | James M. Leu | Means for cleaning of health care instruments |
US5297310A (en) | 1993-01-21 | 1994-03-29 | Dennis Cox | Cleaning brush for endoscopes |
US5269771A (en) | 1993-02-24 | 1993-12-14 | Thomas Medical Products, Inc. | Needleless introducer with hemostatic valve |
US5407807A (en) | 1993-04-23 | 1995-04-18 | Daymark Medical Industries, Inc. | Method and apparatus for detecting sepsis causation in a catheter |
FR2704527B1 (en) | 1993-04-26 | 1995-06-30 | Oreal | COMBINATION OF A CONTAINER BATTERY AND A CAP CAP, AND A CONTAINER AND A CAP ASSEMBLY. |
US5352410A (en) | 1993-06-03 | 1994-10-04 | Hansen Warren D | Fluid specimen collection and testing apparatus |
US5428070A (en) | 1993-06-11 | 1995-06-27 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity |
US5370640A (en) | 1993-07-01 | 1994-12-06 | Kolff; Jack | Intracorporeal catheter placement apparatus and method |
JPH0761482A (en) | 1993-08-20 | 1995-03-07 | Kanae:Kk | Storage container for cap which is used for medical care |
JPH09504274A (en) | 1993-09-17 | 1997-04-28 | ブリガム アンド ウィメンズ ホスピタル | Use of nitric oxide adducts to prevent thrombosis on artificial and vascular surfaces |
US6255277B1 (en) | 1993-09-17 | 2001-07-03 | Brigham And Women's Hospital | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US6087479A (en) | 1993-09-17 | 2000-07-11 | Nitromed, Inc. | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US5354267A (en) | 1993-09-20 | 1994-10-11 | Vital Signs Inc. | Irrigation and suction apparatus |
DE4334272C2 (en) | 1993-10-07 | 1996-07-18 | Stemberger Axel Dr | Coating for biomaterial and its use |
US5375589A (en) | 1993-10-18 | 1994-12-27 | Bhatta; Krishna M. | Unique cleaning catheter |
US5620088A (en) | 1993-11-02 | 1997-04-15 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement for contact lenses |
US5409012A (en) | 1993-12-30 | 1995-04-25 | Boston Scientific Corporation | Sample collection using catheter with expandable member |
US5536258A (en) | 1994-02-14 | 1996-07-16 | Fresenius Usa, Inc. | Antibacterial medical tubing connector |
US5628733A (en) | 1994-03-03 | 1997-05-13 | Izi Corporation | Surgical drain |
US5470307A (en) | 1994-03-16 | 1995-11-28 | Lindall; Arnold W. | Catheter system for controllably releasing a therapeutic agent at a remote tissue site |
US6171287B1 (en) | 1998-05-29 | 2001-01-09 | Lawrence A. Lynn | Luer receiver and method for fluid transfer |
US7033339B1 (en) | 1998-05-29 | 2006-04-25 | Becton Dickinson And Company (Part Interest) | Self sealing luer receiving stopcock |
US5639310A (en) | 1994-06-10 | 1997-06-17 | Giampaolo, Jr.; Joseph L. | Method for manually disinfecting and cleaning post or pierced earrings |
US5583101A (en) | 1994-07-15 | 1996-12-10 | Harvard College | Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
US5496284A (en) | 1994-09-27 | 1996-03-05 | Waldenburg; Ottfried | Dual-chamber syringe & method |
US5554127A (en) | 1994-10-11 | 1996-09-10 | Sherwood Medical Company | Syringe needle thimble cap and method of use thereof |
DE9419630U1 (en) | 1994-12-09 | 1995-02-02 | Fresenius AG, 61352 Bad Homburg | Device for closing a line |
US5624402A (en) | 1994-12-12 | 1997-04-29 | Becton, Dickinson And Company | Syringe tip cap |
US5554135A (en) | 1995-02-17 | 1996-09-10 | Menyhay; Steve Z. | Sterile medical injection port and cover method and apparatus |
US5605696A (en) | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US5584386A (en) | 1995-04-04 | 1996-12-17 | Ahonen; Peggy S. | Container for safely storing and disinfecting used medical instruments |
US5665077A (en) | 1995-04-24 | 1997-09-09 | Nitrosci Pharmaceuticals Llc | Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis |
US5620427A (en) | 1995-04-27 | 1997-04-15 | David R. Kipp | Luer lock system |
US5839715A (en) | 1995-05-16 | 1998-11-24 | Alaris Medical Systems, Inc. | Medical adapter having needleless valve and sharpened cannula |
GB9510241D0 (en) | 1995-05-20 | 1995-07-19 | Harber Hulya | Dummy cleanser |
US5688253A (en) | 1995-05-31 | 1997-11-18 | Paradis; Joseph R. | Needle locking system |
US6248380B1 (en) | 1995-06-06 | 2001-06-19 | Cryovac, Inc. | Package having a dual-film lid comprising a gas-impermeable film and a delaminatable, gas-permeable film |
JP2941204B2 (en) | 1995-07-03 | 1999-08-25 | アルシン・メディカル・インコーポレーテッド | Medical device cap |
GB9521628D0 (en) | 1995-10-21 | 1996-01-03 | Bowd Denise | Improvements in or relating to cleaning arrangements |
JPH09216661A (en) | 1996-02-08 | 1997-08-19 | Omori Mach Co Ltd | Package |
US5810792A (en) | 1996-04-03 | 1998-09-22 | Icu Medical, Inc. | Locking blunt cannula |
US5722537A (en) | 1996-06-11 | 1998-03-03 | Sigler; Elizabeth | Disinfectant container for pacifier or nipple |
US5820604A (en) | 1996-06-11 | 1998-10-13 | Endolap, Inc. | Cannula cap including yeildable outer seal and flapper valve |
US5971972A (en) | 1996-06-27 | 1999-10-26 | Rosenbaum; Jay D. | Failsafe intravenous transfusion system for typed blood |
US5770645A (en) | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US6232434B1 (en) | 1996-08-02 | 2001-05-15 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US6179141B1 (en) | 1996-08-06 | 2001-01-30 | Kenji Nakamura | Container assembly provided with anitbacterial agent against slow-leak bacteria |
US5797887A (en) | 1996-08-27 | 1998-08-25 | Novovasc Llc | Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation |
DK172941B1 (en) | 1996-09-18 | 1999-10-11 | Coloplast As | A urinary catheter assembly |
US5807343A (en) | 1996-09-30 | 1998-09-15 | Becton Dickinson And Company | Protective sealing barrier for a syringe |
DE29617133U1 (en) | 1996-10-02 | 1997-01-02 | Wirth, Christian, 94377 Steinach | Pacifier cleaning device |
ES2140973T3 (en) | 1996-11-01 | 2000-03-01 | Coloplast As | URINARY PROBE ASSEMBLY PROVIDED WITH A READY TO USE PROBE |
BR9807092A (en) | 1997-01-23 | 2000-04-18 | Kyoseki Sangyo Co Ltda | Double self-sealing tube joint |
US6206134B1 (en) | 1997-03-08 | 2001-03-27 | Wayne T. Stark | Cover for stethoscope head |
US6045623A (en) | 1997-04-24 | 2000-04-04 | Cannon; Bradley Jay | Method and apparatus for cleaning catheter lumens |
US5951519A (en) * | 1997-04-25 | 1999-09-14 | Dsu Medical Corporation | Aseptic female connector |
DE19718543A1 (en) | 1997-05-02 | 1998-11-05 | Braun Melsungen Ag | Flexible, tight multi-chamber bag |
US5989229A (en) * | 1997-05-28 | 1999-11-23 | Becton, Dickinson And Company | Needle cover assembly having self-contained drug applicator |
US5902631A (en) | 1997-06-03 | 1999-05-11 | Wang; Lixiao | Lubricity gradient for medical devices |
US6402207B1 (en) | 1997-06-09 | 2002-06-11 | Qd Enterprises, Llc | Safety indexed medical connectors |
US6158614A (en) | 1997-07-30 | 2000-12-12 | Kimberly-Clark Worldwide, Inc. | Wet wipe dispenser with refill cartridge |
US5941857A (en) * | 1997-09-12 | 1999-08-24 | Becton Dickinson And Company | Disposable pen needle |
USD416086S (en) | 1997-10-09 | 1999-11-02 | B. Braun Medical, Inc. | Blunt cannula spike adapter |
GB2330133B (en) | 1997-10-10 | 2001-11-07 | Beeson & Sons Ltd | Closure assembly for pressurized containers |
US5994444A (en) | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
US6605751B1 (en) | 1997-11-14 | 2003-08-12 | Acrymed | Silver-containing compositions, devices and methods for making |
GB2333097B (en) | 1998-01-10 | 2002-07-24 | Michael James Prince | Device for sterilising open beverage containers |
WO1999055396A1 (en) | 1998-04-27 | 1999-11-04 | Surmodics, Inc. | Bioactive agent release coating |
US6117114A (en) | 1998-05-07 | 2000-09-12 | Paradis; Joseph R. | Swabbable needleless valve adaptations |
US6207855B1 (en) | 1998-06-23 | 2001-03-27 | Duke University Medical Center | Stable no-delivering compounds |
US6093743A (en) | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
US6041805A (en) | 1998-07-07 | 2000-03-28 | Imation Corp. | Valve assembly for a removable ink cartridge |
US6605294B2 (en) | 1998-08-14 | 2003-08-12 | Incept Llc | Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
EP0982234A1 (en) | 1998-08-22 | 2000-03-01 | Crown Cork & Seal Technologies Corporation | Closure cap |
FR2782910B1 (en) | 1998-09-04 | 2001-06-15 | Fabrice Mathy | ANTISEPTIC BOX FOR STETHOSCOPE |
US6379691B1 (en) | 1998-09-29 | 2002-04-30 | Medtronic/Ave, Inc. | Uses for medical devices having a lubricious, nitric oxide-releasing coating |
US6394983B1 (en) | 1998-10-28 | 2002-05-28 | Abbott Laboratories | Cap and luer connector for a fluid transfer device |
US6725492B2 (en) | 1998-11-25 | 2004-04-27 | Neosci Medical, Inc. | Cleaning brush for medical devices |
JP3544311B2 (en) | 1998-11-30 | 2004-07-21 | 株式会社大協精工 | Injection nozzle cap |
US6250315B1 (en) | 1998-12-30 | 2001-06-26 | Joel A. Ernster | Device for cleaning nasal coagulator |
US6071413A (en) | 1999-01-13 | 2000-06-06 | Texaco Inc. | Process for removing organic and inorganic contaminants from phenolic stripped sour water employing reverse omosis |
US6105812A (en) | 1999-01-21 | 2000-08-22 | Riordan; Dennis | Dual chamber container |
US6079449A (en) | 1999-02-01 | 2000-06-27 | Waterfall Company, Inc. | System for delivering and maintaining the sterility and integrity of flowable materials |
US6068475A (en) | 1999-02-11 | 2000-05-30 | Stoyka, Jr.; Frank S. | Flavored and medicated therapeutic mouthpiece |
US6245056B1 (en) | 1999-02-12 | 2001-06-12 | Jack M. Walker | Safe intravenous infusion port injectors |
JP4622020B2 (en) | 1999-02-26 | 2011-02-02 | 住友電気工業株式会社 | Oxide superconducting wire having insulating coating and method for producing the same |
US6095356A (en) | 1999-03-10 | 2000-08-01 | Children's Medical Center Corp. | Vented flask cap for absorbing radioactive gases |
US6202870B1 (en) | 1999-03-29 | 2001-03-20 | Woodrow W. Pearce | Venting cap |
US6716396B1 (en) | 1999-05-14 | 2004-04-06 | Gen-Probe Incorporated | Penetrable cap |
US6183450B1 (en) | 1999-06-04 | 2001-02-06 | William A Lois | Catheter de-clogging device |
EP1813293A3 (en) | 1999-06-04 | 2007-10-03 | Oxibio, Inc. | Anti-infective medical device and production method |
GB9914137D0 (en) | 1999-06-17 | 1999-08-18 | Bestfoods | One piece lid for a receptacle |
US6679870B1 (en) | 1999-07-23 | 2004-01-20 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
US6685694B2 (en) | 1999-07-23 | 2004-02-03 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
US7052711B2 (en) | 1999-09-02 | 2006-05-30 | Rice University | Nitric oxide-producing hydrogel materials |
US7279176B1 (en) | 1999-09-02 | 2007-10-09 | Rice University | Nitric oxide-producing hydrogel materials |
US6315761B1 (en) | 1999-09-29 | 2001-11-13 | Alexis Shcherbina | Injection device with bellowed reservoir |
US6232406B1 (en) | 1999-09-30 | 2001-05-15 | Replication Medical Inc. | Hydrogel and method of making |
CN2402327Y (en) | 2000-01-19 | 2000-10-25 | 王平 | Sterilizing cotton |
AU4757901A (en) | 2000-03-20 | 2001-10-03 | Novovascular Inc | Matrices containing nitric oxide donors and reducing agents and their use |
US6943035B1 (en) | 2000-05-19 | 2005-09-13 | Genetix Limited | Liquid dispensing apparatus and method |
US6632199B1 (en) | 2000-05-23 | 2003-10-14 | Becton Dickinson And Company | Syringe assembly including plastic tip cap |
US20020077693A1 (en) | 2000-12-19 | 2002-06-20 | Barclay Bruce J. | Covered, coiled drug delivery stent and method |
US6237800B1 (en) | 2000-06-30 | 2001-05-29 | Anne Scott Barrett | Dual purpose water bottle |
US7049308B2 (en) | 2000-10-26 | 2006-05-23 | Duke University | C-nitroso compounds and use thereof |
US6359182B1 (en) | 2000-10-26 | 2002-03-19 | Duke University | C-nitroso compounds and use thereof |
AU2002239436B2 (en) | 2000-10-31 | 2007-04-26 | Cook Medical Technologies Llc | Coated implantable medical device |
BR0016957A (en) | 2000-12-15 | 2004-06-22 | Narayan Badari Nagarada Gadde | Arterial venous graft with drug delivery system (s) and process for treating sequential biological events that occur in response to graft implantation and drug delivery system |
EP1343436A4 (en) | 2000-12-19 | 2008-05-28 | Vascular Architects Inc | Biologically active agent delivery apparatus and method |
US7329412B2 (en) | 2000-12-22 | 2008-02-12 | The Trustees Of Columbia University In The City Of New York | Antimicrobial medical devices containing chlorhexidine free base and salt |
DE10114247A1 (en) | 2001-03-22 | 2002-10-10 | Heraeus Kulzer Gmbh & Co Kg | Antibiotic / antibiotics-polymer combination |
JP2002291906A (en) | 2001-03-30 | 2002-10-08 | Terumo Corp | Connector and medical instrument |
JP4035695B2 (en) | 2001-04-12 | 2008-01-23 | Smc株式会社 | Pipe fitting |
US6569525B2 (en) | 2001-04-25 | 2003-05-27 | W. R. Grace & Co.-Conn. | Highly dispersible reinforcing polymeric fibers |
US6585691B1 (en) | 2001-05-11 | 2003-07-01 | Jonathan J. Vitello | Tamper evident end cap assembly for a loaded syringe and process |
US6550493B2 (en) | 2001-06-13 | 2003-04-22 | Baxter International Inc. | Vacuum demand valve |
US7311698B2 (en) | 2001-09-24 | 2007-12-25 | Coloplast A/S | Urinary catheter assembly allowing for non-contaminated insertion of the catheter into a urinary canal |
US20040034329A1 (en) | 2001-07-13 | 2004-02-19 | Mankus Rita A | Devices and methods for infusing a liquid into a catheter |
US6444318B1 (en) | 2001-07-17 | 2002-09-03 | Surmodics, Inc. | Self assembling monolayer compositions |
WO2003015677A1 (en) | 2001-07-23 | 2003-02-27 | Novovascular, Inc. | Nitric oxide releasing eptfe coated medical device sandwich |
US6964349B2 (en) | 2001-09-14 | 2005-11-15 | Fort James Corporation | Dispenser with auto-start tab |
JP3972665B2 (en) | 2002-01-25 | 2007-09-05 | 株式会社ジェイ・エム・エス | Aseptic connector system |
US6911025B2 (en) | 2002-01-25 | 2005-06-28 | Jms Co., Ltd. | Connector system for sterile connection |
US7708714B2 (en) | 2002-02-11 | 2010-05-04 | Baxter International Inc. | Dialysis connector with retention and feedback features |
US7198611B2 (en) | 2002-02-11 | 2007-04-03 | Baxter International Inc. | Dialysis connector and cap having an integral disinfectant |
JP3504249B2 (en) | 2002-02-12 | 2004-03-08 | 大日本印刷株式会社 | Multiple container |
GB0203933D0 (en) | 2002-02-20 | 2002-04-03 | Smith David | Portable dummy sterilizer |
AU2003237128A1 (en) | 2002-05-03 | 2003-11-17 | Duke University | Carbon nanotubules for storage of nitric oxide |
US7160272B1 (en) | 2002-05-31 | 2007-01-09 | Elcam Plastic | Y-site medical valve |
US7097850B2 (en) | 2002-06-18 | 2006-08-29 | Surmodics, Inc. | Bioactive agent release coating and controlled humidity method |
EP1534379B1 (en) | 2002-08-09 | 2008-12-03 | E-WHA Fresenius Kabi Inc. | Cap of tube for supplying liquid |
US20040034042A1 (en) | 2002-08-14 | 2004-02-19 | Masao Tsuji | Preservative composition |
US6992028B2 (en) | 2002-09-09 | 2006-01-31 | Kimberly-Clark Worldwide, Inc. | Multi-layer nonwoven fabric |
US20030039697A1 (en) | 2002-09-12 | 2003-02-27 | Yi-Ju Zhao | Matrices containing nitric oxide donors and reducing agents and their use |
US7056308B2 (en) | 2002-10-04 | 2006-06-06 | Dsu Medical Corporation | Medical device with elastomeric penetrable wall and inner seal |
US6827766B2 (en) | 2002-10-08 | 2004-12-07 | United States Air Force | Decontaminating systems containing reactive nanoparticles and biocides |
FR2845921A1 (en) | 2002-10-16 | 2004-04-23 | Vygon | Connector and lock for tubes used in medicine has lock capable of transverse elastic deformation to grip female component of connector |
ATE354380T1 (en) | 2003-02-03 | 2007-03-15 | Polaschegg Hans-Dietrich Dr Te | COMPOSITION FOR THE PREVENTION OF INFECTIONS THROUGH SUBCUTANEOUS PROSTHESIS |
ITMI20030713A1 (en) | 2003-04-09 | 2004-10-10 | Capsol Berry Plastics S P A | ELASTICALLY DEFORMABLE VALVE WITH AUTOMATIC CLOSURE |
DE10317665A1 (en) | 2003-04-17 | 2004-11-11 | Bernd Hansen | ampoule |
USD493526S1 (en) | 2003-04-22 | 2004-07-27 | Becton, Dickinson And Company | Syringe tip cap |
US7195615B2 (en) | 2003-05-14 | 2007-03-27 | Boston Scientific Scimed, Inc. | System for providing a medical device with anti-microbial properties |
PT1644024T (en) | 2003-06-06 | 2019-10-24 | Univ Texas | Antimicrobial flush solutions |
US7282186B2 (en) | 2003-06-20 | 2007-10-16 | Lake Jr Robert F | Decontamination device |
US7972137B2 (en) | 2003-06-30 | 2011-07-05 | Rosen Gerald M | Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease |
WO2007086876A2 (en) | 2005-02-10 | 2007-08-02 | Wilson-Cook Medical Inc. | Wire guide holder with wire guide deflector |
KR100940701B1 (en) | 2003-07-31 | 2010-02-08 | 가부시끼가이샤 제이엠에스 | Connector system for medical use |
US20050098527A1 (en) | 2003-09-15 | 2005-05-12 | Yates William M.Iii | Multiple cavity bottle and method of manufacturing same |
US7534233B2 (en) | 2003-09-23 | 2009-05-19 | Becton, Dickson And Company | Flush syringe having anti-reflux features |
US20050228482A1 (en) | 2003-09-26 | 2005-10-13 | William Herzog | Stent covered by a layer having a layer opening |
US7309326B2 (en) | 2003-11-18 | 2007-12-18 | Icu Medical, Inc. | Infusion set |
US20050124970A1 (en) | 2003-12-05 | 2005-06-09 | Medical Components, Inc. | Luer cap with antibacterial property |
US7108678B2 (en) | 2003-12-31 | 2006-09-19 | Biotop Holding Co., Ltd. | Captive cover for a hypodermic needle of an intravenous (IV) tube assembly |
US20050147524A1 (en) | 2004-01-06 | 2005-07-07 | Bousquet Gerald G. | Sterile tubing termination assembly |
US8282608B2 (en) | 2004-01-29 | 2012-10-09 | Becton, Dickinson And Company | Self priming intravenous delivery system |
GB0402249D0 (en) | 2004-02-02 | 2004-03-03 | Idi Technologies Ltd | Brush |
US20050220882A1 (en) | 2004-03-04 | 2005-10-06 | Wilson Pritchard | Materials for medical implants and occlusive devices |
US7282177B2 (en) | 2004-03-26 | 2007-10-16 | Castaneda C Robert | Stethoscope cleansing unit and business method for providing advertising through the use of stethoscope cleansing unit |
US7067659B2 (en) | 2004-04-23 | 2006-06-27 | Duke University | Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof |
CA2564133A1 (en) | 2004-04-28 | 2005-11-24 | Ams Research Corporation | Endoscopic delivery of medical devices |
WO2005112954A1 (en) | 2004-05-14 | 2005-12-01 | William Marsh Rice University | Nitric oxide releasing compositions and associated methods |
US8791073B2 (en) | 2004-05-14 | 2014-07-29 | William Marsh Rice University | Peptide-modified polyurethane compositions and associated methods |
US20050267421A1 (en) | 2004-05-28 | 2005-12-01 | Wing Thomas W | Catheter cleaner |
CA2573482C (en) | 2004-07-14 | 2013-01-15 | Medical Components, Inc. | Luer cleaner |
US20060011654A1 (en) | 2004-07-16 | 2006-01-19 | Webb Garth T | Disinfectant cap for sterile liquid dispenser |
US20060024372A1 (en) | 2004-07-29 | 2006-02-02 | Utterberg David S | High viscosity antibacterials |
EP1809351A2 (en) | 2004-09-28 | 2007-07-25 | Mallinckrodt, Inc. | Container with constrained quality maintenance agent |
US7731678B2 (en) | 2004-10-13 | 2010-06-08 | Hyprotek, Inc. | Syringe devices and methods for mixing and administering medication |
US8372045B2 (en) | 2004-11-19 | 2013-02-12 | Curlin Medical Inc. | Controlled-volume infusion device |
JP4591680B2 (en) | 2004-12-27 | 2010-12-01 | ライオン株式会社 | Liquid oral composition |
US20060206178A1 (en) | 2005-03-11 | 2006-09-14 | Kim Daniel H | Percutaneous endoscopic access tools for the spinal epidural space and related methods of treatment |
US8465771B2 (en) | 2005-03-30 | 2013-06-18 | The University Of Western Ontario | Anisotropic hydrogels |
US7806291B2 (en) | 2005-05-19 | 2010-10-05 | Buckeye Technologies | Center-pull dispenser for web material |
US7682561B2 (en) | 2005-05-19 | 2010-03-23 | Sage Products, Inc. | Needleless hub disinfection device and method |
US7998134B2 (en) | 2007-05-16 | 2011-08-16 | Icu Medical, Inc. | Medical connector |
US20070088292A1 (en) | 2005-07-06 | 2007-04-19 | Fangrow Thomas F Jr | Medical connector with closeable male luer |
US8778369B2 (en) | 2005-07-29 | 2014-07-15 | Delaval Holding Ab | Barrier film-forming compositions and methods of use |
CN2815392Y (en) | 2005-08-19 | 2006-09-13 | 张利国 | Self-ruined leakage-free disposable syringe |
US7766182B2 (en) | 2005-10-12 | 2010-08-03 | Parker-Hannifin Corporation | Cap with threaded gasket vent |
US7928079B2 (en) | 2005-10-31 | 2011-04-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
BRPI0617780A2 (en) | 2005-11-09 | 2011-08-09 | Hyprotek Inc | syringe devices, syringe device components, and methods of forming syringe components and devices |
US8740864B2 (en) | 2005-11-17 | 2014-06-03 | Becton, Dickinson And Company | Patient fluid line access valve antimicrobial cap/cleaner |
EP1798554A1 (en) | 2005-12-13 | 2007-06-20 | Millimed A/S | Method and system for measurement of nitrite and nitric oxide release |
WO2007073939A1 (en) | 2005-12-28 | 2007-07-05 | Covidien Ag | Male leur connector |
US7766897B2 (en) | 2006-01-02 | 2010-08-03 | Carefusion 303, Inc. | Protective priming cap for self-sealing male Luer valve |
ITMI20060019U1 (en) | 2006-01-20 | 2007-07-21 | Elesa Spa | BREATHER CAP FOR OIL TANKS FOR MACHINERY AND SIMILAR PARTS |
US8177084B2 (en) | 2006-02-13 | 2012-05-15 | Tripath Imaging, Inc. | Container assembly and pressure-responsive penetrable cap for the same |
AU2007218014A1 (en) | 2006-02-17 | 2007-08-30 | Alan L. Buchman | Catheter cleaning devices |
MX2008011085A (en) | 2006-02-28 | 2008-09-05 | Becton Dickinson Co | Antimicrobial compositions and methods for locking catheters. |
US9895526B2 (en) | 2006-03-08 | 2018-02-20 | Ivaxis, Llc | Anti-contamination cover for fluid connections |
US8361408B2 (en) | 2006-03-16 | 2013-01-29 | Lawrence Allan Lynn | Luer protection pouch and luer valve/male luer protection method |
US20080039803A1 (en) | 2006-08-09 | 2008-02-14 | Lawrence Allan Lynn | Luer protection pouch™ and luer valve/male luer protection method |
US7794675B2 (en) | 2006-03-16 | 2010-09-14 | Lawrence Allan Lynn | Swab pouch |
US8480968B2 (en) | 2006-08-09 | 2013-07-09 | Lawrence Allan Lynn | Luer valve disinfectant swab-pouch |
JP4965641B2 (en) | 2006-03-24 | 2012-07-04 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Apparatus, system and container for filling a device for personal care treatment, and device for personal care treatment comprising such a container |
US8163237B2 (en) | 2006-05-08 | 2012-04-24 | Becton, Dickinson And Company | Vascular access device pathogenic status indication |
US9592375B2 (en) | 2006-05-18 | 2017-03-14 | Hyprotek, Inc. | Intravascular line and port cleaning methods, methods of administering an agent intravascularly, methods of obtaining/testing blood, and devices for performing such methods |
US8162899B2 (en) | 2006-05-18 | 2012-04-24 | Hyprotek, Inc. | Intravascular line and port cleaning methods, methods of administering an agent intravascularly, methods of obtaining/testing blood, and devices for performing such methods |
US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
US9259535B2 (en) | 2006-06-22 | 2016-02-16 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
US9700710B2 (en) | 2006-06-22 | 2017-07-11 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
US20080033371A1 (en) | 2006-06-26 | 2008-02-07 | Updegraff Debra K | Cover for catheter assembly |
EP2033678A4 (en) | 2006-06-27 | 2012-11-28 | Otsuka Pharma Co Ltd | Powder inhaler |
CN103316403B (en) | 2006-06-30 | 2017-05-24 | 艾伯维生物技术有限公司 | Automatic injection device |
US7780794B2 (en) | 2006-07-21 | 2010-08-24 | Ivera Medical Corporation | Medical implement cleaning device |
US8512294B2 (en) | 2006-07-28 | 2013-08-20 | Becton, Dickinson And Company | Vascular access device antimicrobial materials and solutions |
US20080027399A1 (en) | 2006-07-28 | 2008-01-31 | Becton, Dickinson And Company | Antimicrobial vascular access device |
JP5048776B2 (en) | 2006-09-29 | 2012-10-17 | タイコ ヘルスケア グループ リミテッド パートナーシップ | Surgical fluid transfer device |
DE102006050212A1 (en) | 2006-10-25 | 2008-04-30 | Fresenius Kabi Deutschland Gmbh | Connecting piece for enteral transfer system, has distal attachment piece of connection tube with locking element, that is formed so that form-fit detaching connection is produced with connection piece of probe tube of enteral feed tube |
US8377040B2 (en) | 2006-11-06 | 2013-02-19 | Becton, Dickinson And Company | Extravascular system venting |
US8066670B2 (en) | 2006-11-06 | 2011-11-29 | Becton, Dickinson And Company | Vascular access device septum venting |
US20080128646A1 (en) | 2006-12-05 | 2008-06-05 | Humitek, Inc. | Splines and caps for fluid ports |
US20080147047A1 (en) | 2006-12-18 | 2008-06-19 | Sage Products, Inc. | Needleless Hub Disinfection Device and Method |
US8177761B2 (en) | 2007-01-16 | 2012-05-15 | The University Of Utah Research Foundation | Assembly for cleaning luer connectors |
US8523831B2 (en) | 2009-10-30 | 2013-09-03 | Catheter Connections, Inc. | Disinfecting caps having sealing features and related systems and methods |
US7935091B2 (en) | 2007-01-16 | 2011-05-03 | Bousquet Gerald G | Catheter extension set and closure assembly therefor |
US8172825B2 (en) | 2007-01-16 | 2012-05-08 | The University Of Utah Research Foundation | Methods for disinfecting medical connectors |
US8328767B2 (en) | 2007-01-16 | 2012-12-11 | Catheter Connections, Inc. | Disinfecting caps for medical male luer connectors |
US8523830B2 (en) * | 2007-01-16 | 2013-09-03 | Catheter Connections | Disinfecting caps for medical female luer connectors |
JP2010516342A (en) | 2007-01-16 | 2010-05-20 | ザ・ユニバーシティ・オブ・ユタ・リサーチ・ファウンディション | Nested sterilization protection cap for isolated connectors |
US8419713B1 (en) | 2012-08-01 | 2013-04-16 | The University Of Utah Research Foundation | Carrier assembly with caps for medical connectors |
CA2574551A1 (en) | 2007-01-19 | 2008-07-19 | Joseph E. Dadson, Sr. | Connectology system |
JP4886535B2 (en) | 2007-01-30 | 2012-02-29 | 日本コヴィディエン株式会社 | Connector cap |
DE102007005407A1 (en) | 2007-02-03 | 2008-08-07 | Fresenius Kabi Deutschland Gmbh | Cap for a container for holding medical fluids and container for receiving medical fluids |
US9259284B2 (en) | 2007-02-12 | 2016-02-16 | 3M Innovative Properties Company | Female Luer connector disinfecting cap |
US9192449B2 (en) | 2007-04-02 | 2015-11-24 | C. R. Bard, Inc. | Medical component scrubbing device with detachable cap |
US8065773B2 (en) | 2007-04-02 | 2011-11-29 | Bard Access Systems, Inc. | Microbial scrub brush |
US8336152B2 (en) | 2007-04-02 | 2012-12-25 | C. R. Bard, Inc. | Insert for a microbial scrubbing device |
BRPI0811479A2 (en) | 2007-05-02 | 2014-11-04 | Marcio Marc Abreu | BOTTLE FOR DISPENSING FLUIDS |
US20100253070A1 (en) | 2007-06-30 | 2010-10-07 | Cheon Peter | Coupling with automatic seal |
US20090024096A1 (en) * | 2007-07-20 | 2009-01-22 | Baxter International Inc. | Immobilization of dyes and antimicrobial agents on a medical device |
US20090028750A1 (en) | 2007-07-23 | 2009-01-29 | Ryan Dana Wm | Cleaning and Disinfection Swabbing Device for Needle-Free Intravenous (IV) Connectors |
US8002737B2 (en) | 2007-10-04 | 2011-08-23 | Hyprotek, Inc. | Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers |
US8113837B2 (en) | 2007-11-26 | 2012-02-14 | Peter John Zegarelli | Oral appliance for delivering a medicament |
US20090137969A1 (en) | 2007-11-26 | 2009-05-28 | Colantonio Anthony J | Apparatus and method for sterilizing a tubular medical line port |
US20100143427A1 (en) | 2008-12-05 | 2010-06-10 | King Joseph A | Antimicrobial Surfaces |
CN201150420Y (en) | 2007-12-20 | 2008-11-19 | 武汉市第十一中学 | Carried type sterilized telescopic chopsticks |
US7704002B2 (en) | 2008-02-19 | 2010-04-27 | Medical Components, Inc. | Luer cleaner with self-puncturing reservoir |
US8388894B2 (en) | 2008-03-20 | 2013-03-05 | Psi Medical Catheter Care, Llc | Apparatus and method for sterilizing a tubular medical line port |
US8696820B2 (en) | 2008-03-31 | 2014-04-15 | Bard Access Systems, Inc. | Method of removing a biofilm from a surface |
US9408971B2 (en) | 2008-03-31 | 2016-08-09 | Covidien Lp | Self-capping syringe assembly with one-way valve |
US20090259194A1 (en) | 2008-04-11 | 2009-10-15 | Raffi Pinedjian | Keyed Safety Cap and Receptacle for Two Piece Injection Device |
US20090270832A1 (en) | 2008-04-23 | 2009-10-29 | Baxter International Inc. | Needleless port assembly for a container |
WO2009136957A1 (en) | 2008-05-06 | 2009-11-12 | Ferlic Michael J | Universal sterilizing tool |
US9572904B2 (en) | 2008-05-06 | 2017-02-21 | Michael J. Ferlic | Sterilizing device with pinch actuated cap and housing |
US8252247B2 (en) | 2008-05-06 | 2012-08-28 | Ferlic Michael J | Universal sterilizing tool |
US8617482B2 (en) | 2008-06-17 | 2013-12-31 | Gambro Lundia Ab | Maintaining sterile conditions in a fluid transportation system |
JP5165479B2 (en) | 2008-07-02 | 2013-03-21 | オリンパスメディカルシステムズ株式会社 | Endoscope cleaning disinfection device |
US20110064512A1 (en) | 2008-07-03 | 2011-03-17 | Shaw Thomas J | Cleaning Tool |
US8777504B2 (en) | 2008-07-03 | 2014-07-15 | Retractable Technologies, Inc. | Cleaning tool |
USD607325S1 (en) | 2008-09-05 | 2010-01-05 | Ivera Medical Corporation | Cleaning cap |
DE102008048988A1 (en) | 2008-09-25 | 2010-04-08 | Fresenius Kabi Deutschland Gmbh | Device for connecting a syringe to a container or a hose line |
CN102281911B (en) | 2008-09-29 | 2014-07-16 | 维福(国际)股份公司 | Cap assembly and production method |
US8069523B2 (en) | 2008-10-02 | 2011-12-06 | Bard Access Systems, Inc. | Site scrub brush |
US8622995B2 (en) | 2009-10-26 | 2014-01-07 | Pursuit Vascular, Inc. | Method for delivery of antimicrobial to proximal end of catheter |
US9022984B2 (en) | 2008-10-27 | 2015-05-05 | Pursuit Vascular, Inc. | Apparatus for delivery of device and antimicrobial agent into trans-dermal catheter |
US8622996B2 (en) | 2008-10-27 | 2014-01-07 | Pursuit Vascular, Inc. | Method for applying antimicrobial to proximal end of catheter |
US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
US20100152670A1 (en) | 2008-12-17 | 2010-06-17 | Tzu-Yi LOW | Safety needle cap for syringe |
WO2010108116A1 (en) | 2009-03-20 | 2010-09-23 | Antares Pharma, Inc. | Hazardous agent injection system |
US9433209B2 (en) | 2009-03-26 | 2016-09-06 | Organic Medical Ventures, L.L.C. | Transdermal venous access locking solutions |
BRPI1011707A2 (en) | 2009-06-01 | 2019-09-24 | Ivera Medical Corp | "Friction-based medical instrument cleaning device" |
US9125600B2 (en) | 2009-06-29 | 2015-09-08 | Gregory A. Steube | Medical device with incorporated disinfecting wipe and method of using same |
CN104873389B (en) | 2009-07-29 | 2017-12-05 | Icu医学有限公司 | Fluid conveying device and application method |
US9566391B2 (en) | 2009-08-20 | 2017-02-14 | Bing-Tang Zhong | Protective needle shield |
US9821119B2 (en) | 2009-08-21 | 2017-11-21 | Becton Dickinson France | Syringe assembly with pivoting plunger and integral tip guard |
US9149624B2 (en) | 2009-09-02 | 2015-10-06 | Carefusion 303, Inc. | Disinfecting male luer connector caps |
EP2480281B1 (en) | 2009-09-04 | 2018-11-07 | B. Braun Melsungen AG | Selectively sealable male needleless connectors |
US8764731B2 (en) | 2009-10-02 | 2014-07-01 | Medline Industries, Inc. | Connector for fluid conduit with integrated luer access port |
CN201519335U (en) * | 2009-10-21 | 2010-07-07 | 天津市海河医院 | Anti-pollution structure of medial remaining needle positive pressure connector |
WO2011053924A1 (en) | 2009-10-30 | 2011-05-05 | Catheter Connections, Inc. | Disinfecting caps and systems and associated methods |
WO2011066565A1 (en) | 2009-11-30 | 2011-06-03 | Catheter Connections, Inc. | Disinfecting caps having an extendable feature and related systems and methods |
EP3409313B1 (en) | 2009-12-04 | 2020-12-02 | Becton, Dickinson and Company | Self-injection device with multi-position cap |
US8533887B2 (en) | 2009-12-23 | 2013-09-17 | Sandra B. Hirst | Apparatus for disinfecting handheld instruments |
WO2011119021A1 (en) | 2010-03-23 | 2011-09-29 | N.V. Nutricia | Three-way stop cock for enteral tube feeding applications |
US20110232020A1 (en) | 2010-03-26 | 2011-09-29 | Ivera Medical Corporation | Medical implement cleaning device with friction-based fitting and energy directors |
US20110314619A1 (en) | 2010-06-23 | 2011-12-29 | Medical Components, Inc. | Cleaner for Medical Device |
US8721627B2 (en) | 2010-07-22 | 2014-05-13 | Carefusion 303, Inc. | Needleless valve infection prevention and pre-opening device |
EP2444117A1 (en) | 2010-10-20 | 2012-04-25 | Fresenius Kabi Deutschland GmbH | Protective cap for a connector |
DE102010061061A1 (en) | 2010-12-07 | 2012-06-14 | Alfred Von Schuckmann | syringe cap |
BR112013021027A2 (en) | 2011-02-18 | 2016-10-11 | Ivera Medical Corp | medical implement cleaning system |
EP2681286B1 (en) | 2011-02-28 | 2018-08-15 | Novan, Inc. | Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same |
WO2012162259A2 (en) | 2011-05-20 | 2012-11-29 | Excelsior Medical Corporation | Caps for cannula access devices |
US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
US9867975B2 (en) | 2011-05-23 | 2018-01-16 | Excelsior Medical Corporation | Antiseptic line cap |
WO2013009478A1 (en) | 2011-07-08 | 2013-01-17 | Icu Medical, Inc. | Sheath |
US8697112B2 (en) | 2011-07-08 | 2014-04-15 | Covalon Technologies | Method for treating a surface with a coating comprising a microencapsulated therapeutic agent and device with treated surface |
WO2013009998A2 (en) | 2011-07-12 | 2013-01-17 | Pursuit Vascular, Inc. | Device for delivery of antimicrobial agent into trans-dermal catheter |
US20130053751A1 (en) | 2011-08-31 | 2013-02-28 | Frank Holtham | Needle with an antiseptic swab |
ES2813967T3 (en) | 2011-09-09 | 2021-03-25 | Icu Medical Inc | Medical connectors with fluid resistant mating interfaces |
US8979724B2 (en) | 2011-09-30 | 2015-03-17 | Teikoku Pharma Usa, Inc. | General medication disposal system |
US20130098938A1 (en) | 2011-10-25 | 2013-04-25 | Sotiria Efthimiadis | Wipes dispenser |
US20130134161A1 (en) | 2011-11-30 | 2013-05-30 | Lawrence Fogel | Dual compartment package for dispensing fluids |
US8628501B2 (en) | 2011-12-21 | 2014-01-14 | Gordon Hadden | Syringe sterilization cap |
US8809614B2 (en) | 2012-01-16 | 2014-08-19 | Jerry M. Wilhoit | Dental wound dressing |
US9216440B2 (en) | 2012-05-31 | 2015-12-22 | Becton, Dickinson And Company | Systems and methods to monitor proper disinfection of needleless connectors |
AU2013271786B2 (en) | 2012-06-04 | 2017-11-02 | 3M Innovative Properties Company | Male medical implement cleaning device |
US8758307B2 (en) | 2012-06-15 | 2014-06-24 | B. Braun Medical Inc. | Self-priming, anti-free flow valve for infusion pumps |
CN204275094U (en) | 2012-06-22 | 2015-04-22 | 美国昊朗国际公司 | To the antimicrobial equipment that armarium uses together and relevant assembly |
US8651271B1 (en) | 2012-08-08 | 2014-02-18 | Tzu-Yuan Shen | Container with multiple chambers and multiple openings |
US9302049B2 (en) | 2012-08-20 | 2016-04-05 | Becton, Dickinson And Company | Medical devices for blood reflux prevention and methods of use |
CA2891255C (en) | 2012-11-12 | 2022-10-04 | Icu Medical, Inc. | Medical connector |
US9233208B2 (en) | 2012-11-29 | 2016-01-12 | Becton, Dickinson And Company | Methods and apparatus for disinfecting and reflux prevention flush syringe assembly |
JP2014117461A (en) | 2012-12-17 | 2014-06-30 | Fukai Kogyo Kk | Coinjection tube |
WO2014115566A1 (en) | 2013-01-28 | 2014-07-31 | テルモ株式会社 | Tube connection structure |
US9352141B2 (en) | 2013-02-08 | 2016-05-31 | Elizabeth Wong | Double-lock sterile entry intravenous port and syringe system |
US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US9399125B2 (en) | 2013-02-13 | 2016-07-26 | Becton, Dickinson And Company | Needleless connector and access port disinfection cleaner and antimicrobial protection cap |
US9039989B2 (en) | 2013-02-13 | 2015-05-26 | Becton, Dickinson And Company | Disinfection cap for disinfecting a male luer end of an infusion therapy device |
EP2774650A1 (en) | 2013-03-04 | 2014-09-10 | Debiotech S.A. | Cap connector assembly |
ITPR20130017A1 (en) | 2013-03-11 | 2014-09-12 | Gea Procomac Spa | CLOSING TREATMENT SYSTEM FOR CONTAINERS USING A STERILIZING SUBSTANCE |
WO2014159346A1 (en) | 2013-03-14 | 2014-10-02 | Excelsior Medical Corporation | Antiseptic dead-end cap |
US9907617B2 (en) | 2013-03-15 | 2018-03-06 | 3M Innovative Properties Company | Medical implement cleaning device |
EP3033133B1 (en) | 2013-08-16 | 2020-04-15 | Np Medical Inc. | Catheter stabilization device |
ITMI20131610A1 (en) | 2013-09-30 | 2015-03-31 | Nex Medical S A S Di Villa Annamar Ia & C | DEVICE TO DISINFECT CONNECTORS |
EP2862587A1 (en) | 2013-10-15 | 2015-04-22 | Becton Dickinson France | Tip cap assembly for closing an injection system |
TWM480392U (en) | 2013-10-16 | 2014-06-21 | Yi Jin Promold Entpr Ltd | Anti-backflow medical connector |
JP6461174B2 (en) | 2014-02-04 | 2019-01-30 | アイシーユー・メディカル・インコーポレーテッド | Self-priming system and self-priming method |
AU2015213707A1 (en) | 2014-02-06 | 2016-07-14 | Excelsior Medical Corporation | Swab devices |
US20170042636A1 (en) | 2014-02-14 | 2017-02-16 | The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust | Disinfecting device |
CA2945406C (en) | 2014-05-02 | 2022-10-18 | Excelsior Medical Corporation | Strip package for antiseptic cap |
EP3142711B1 (en) | 2014-05-14 | 2019-01-09 | Health Line International Corp. | Antimicrobial devices for use with medical devices and related assemblies and methods |
AU2015301609B2 (en) | 2014-08-13 | 2020-03-26 | Excelsior Medical Corporation | Disinfectant caps |
CA2959393C (en) | 2014-09-08 | 2020-12-29 | Neomed, Inc. | Vented connector for medical fluid vessels |
WO2016040360A1 (en) | 2014-09-09 | 2016-03-17 | Byeong Seon Chang | Solution delivery device and method |
JP6368603B2 (en) | 2014-09-25 | 2018-08-01 | テルモ株式会社 | Disinfection cap |
MX2017003787A (en) | 2014-09-29 | 2017-05-08 | Becton Dickinson Co | Medical device cap for drug transfer assembly. |
US9604046B2 (en) | 2014-11-03 | 2017-03-28 | Nordson Corporation | Protective caps for use with medical fluid fittings, and related methods |
US10166339B2 (en) | 2014-11-24 | 2019-01-01 | Merit Medical Systems, Inc. | Disinfecting cap for medical connectors |
US9527660B2 (en) | 2014-12-31 | 2016-12-27 | Hyprotek, Inc. | Individually sealed antiseptic applicators |
CN106902402A (en) | 2015-12-22 | 2017-06-30 | 徐�明 | A kind of automatic blood transfusion device |
CN108697875B (en) | 2016-02-18 | 2021-07-23 | 施曼信医疗Asd公司 | Closed system catheter |
WO2018009653A1 (en) | 2016-07-06 | 2018-01-11 | Smiths Medical Asd, Inc. | Closed system catheter vent cap |
FI3525865T3 (en) | 2016-10-14 | 2023-01-13 | Sanitizing caps for medical connectors | |
WO2018140284A1 (en) | 2017-01-27 | 2018-08-02 | Merit Medical Systems, Inc. | Disinfecting luer cap and method of use |
WO2018237090A1 (en) | 2017-06-21 | 2018-12-27 | Icu Medical, Inc. | Priming cap |
JP7495351B2 (en) | 2018-03-16 | 2024-06-04 | アイシーユー・メディカル・インコーポレーテッド | Disinfection Cap for Medical Connectors |
AU2019288655A1 (en) | 2018-06-21 | 2021-01-14 | Icu Medical, Inc. | System for sterilizing intravenous connectors and tubing |
US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
US10525250B1 (en) | 2018-11-07 | 2020-01-07 | Pursuit Vascular, Inc. | Infusion device with antimicrobial properties |
US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
US20220218880A1 (en) | 2019-06-10 | 2022-07-14 | The Regents Of The University Of Michigan | Catheter insert devices |
-
2012
- 2012-07-12 US US13/547,650 patent/US9259535B2/en active Active
- 2012-10-26 JP JP2014540000A patent/JP6087364B2/en active Active
- 2012-10-26 MX MX2014005371A patent/MX345307B/en active IP Right Grant
- 2012-10-26 CA CA2854296A patent/CA2854296C/en active Active
- 2012-10-26 EP EP12845250.5A patent/EP2773398B1/en active Active
- 2012-10-26 AU AU2012332901A patent/AU2012332901B2/en active Active
- 2012-10-26 ES ES12845250T patent/ES2907323T3/en active Active
- 2012-10-26 CN CN201280065923.4A patent/CN104023768B/en active Active
- 2012-10-26 WO PCT/US2012/062078 patent/WO2013066742A1/en active Application Filing
- 2012-10-26 BR BR112014010805-6A patent/BR112014010805B1/en active IP Right Grant
-
2014
- 2014-05-02 CO CO14094083A patent/CO7030941A2/en unknown
-
2015
- 2015-03-10 HK HK15102429.0A patent/HK1201770A1/en unknown
- 2015-07-14 US US14/799,022 patent/US9707350B2/en active Active
-
2017
- 2017-06-29 US US15/637,998 patent/US10328207B2/en active Active
-
2020
- 2020-12-11 US US17/120,015 patent/US11160932B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246011A (en) * | 1992-01-30 | 1993-09-21 | Caillouette James C | Fine needle aspiration syringe |
RU2246321C1 (en) * | 2003-08-04 | 2005-02-20 | Мамаев Геннадий Викторович | Container-type syringe |
US20090062766A1 (en) | 2007-01-16 | 2009-03-05 | Howlett Michael W | Sterility-protecting caps with fluid reservoir for separated connectors |
US20100047123A1 (en) | 2007-01-16 | 2010-02-25 | The University Of Utah Research Foundation | Sterilization caps and systems and associated methods |
WO2009002474A1 (en) | 2007-06-22 | 2008-12-31 | Excelsior Medical | Antiseptic cap with thread cover |
Non-Patent Citations (1)
Title |
---|
See also references of EP2773398A4 |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9186707B2 (en) | 2007-04-02 | 2015-11-17 | C. R. Bard, Inc. | Insert for a microbial scrubbing device |
US9192449B2 (en) | 2007-04-02 | 2015-11-24 | C. R. Bard, Inc. | Medical component scrubbing device with detachable cap |
US9352140B2 (en) | 2007-04-02 | 2016-05-31 | C. R. Bard, Inc. | Medical component scrubbing device with detachable cap |
US10245342B2 (en) | 2012-06-22 | 2019-04-02 | Health Line International Corp. | Antimicrobial devices for use with medical devices and related assemblies and methods |
WO2016174471A1 (en) * | 2015-04-30 | 2016-11-03 | Steven Gill Anaesthetic Services Ltd | Injectables |
US12070570B2 (en) | 2015-04-30 | 2024-08-27 | Safe Iv Ltd. | Injectables |
US11571505B2 (en) | 2015-11-27 | 2023-02-07 | Sanofi-Aventis Deutschland Gmbh | Drug delivery device with a cap |
USD834187S1 (en) | 2016-01-18 | 2018-11-20 | Becton, Dickinson And Company | Disinfecting cap |
US10391295B2 (en) | 2016-01-18 | 2019-08-27 | Becton, Dickinson And Company | Disinfection cap for IV needleless connectors |
US11083883B2 (en) | 2016-01-18 | 2021-08-10 | Becton, Dickinson And Company | Disinfection cap for IV needleless connectors |
US11229783B2 (en) | 2016-01-18 | 2022-01-25 | Becton, Dickinson And Company | Disinfection cap for IV needleless connectors |
US11911586B2 (en) | 2016-01-18 | 2024-02-27 | Becton, Dickinson And Company | Disinfection cap for IV needleless connectors |
Also Published As
Publication number | Publication date |
---|---|
US10328207B2 (en) | 2019-06-25 |
BR112014010805A2 (en) | 2017-05-02 |
CA2854296C (en) | 2021-02-16 |
JP2014532517A (en) | 2014-12-08 |
US11160932B2 (en) | 2021-11-02 |
EP2773398A4 (en) | 2015-06-03 |
US20210093791A1 (en) | 2021-04-01 |
CO7030941A2 (en) | 2014-08-21 |
ES2907323T3 (en) | 2022-04-22 |
US9259535B2 (en) | 2016-02-16 |
CN104023768A (en) | 2014-09-03 |
NZ624449A (en) | 2016-06-24 |
HK1201770A1 (en) | 2015-09-11 |
CN104023768B (en) | 2017-03-08 |
US20150314119A1 (en) | 2015-11-05 |
MX2014005371A (en) | 2014-07-09 |
JP6087364B2 (en) | 2017-03-01 |
AU2012332901B2 (en) | 2017-11-30 |
EP2773398B1 (en) | 2021-12-15 |
MX345307B (en) | 2017-01-25 |
US20170361023A1 (en) | 2017-12-21 |
US20130006194A1 (en) | 2013-01-03 |
EP2773398A1 (en) | 2014-09-10 |
AU2012332901A1 (en) | 2014-05-22 |
CA2854296A1 (en) | 2013-05-10 |
US9707350B2 (en) | 2017-07-18 |
BR112014010805B1 (en) | 2021-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11160932B2 (en) | Antiseptic cap that releases a gas such as nitric oxide | |
US11684720B2 (en) | Antiseptic cap that releases a gas such as nitric oxide | |
US9700677B2 (en) | Antiseptic cap with antiseptic | |
US9700710B2 (en) | Antiseptic cap equipped syringe | |
AU2013100345A4 (en) | Antiseptic cap with thread cover | |
AU2016219664B2 (en) | Antiseptic cap with thread cover | |
AU2014218397B2 (en) | Antiseptic cap with thread cover |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12845250 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2854296 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2014540000 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14094083 Country of ref document: CO Ref document number: MX/A/2014/005371 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012845250 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2012332901 Country of ref document: AU Date of ref document: 20121026 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014010805 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014010805 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140505 |